<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00951496</url>
  </required_header>
  <id_info>
    <org_study_id>NCI-2011-01956</org_study_id>
    <secondary_id>NCI-2011-01956</secondary_id>
    <secondary_id>CDR0000650601</secondary_id>
    <secondary_id>GOG-0252</secondary_id>
    <secondary_id>GOG-0252</secondary_id>
    <secondary_id>U10CA180868</secondary_id>
    <secondary_id>U10CA027469</secondary_id>
    <nct_id>NCT00951496</nct_id>
  </id_info>
  <brief_title>Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer</brief_title>
  <official_title>A Phase III Clinical Trial of Bevacizumab With IV Versus IP Chemotherapy in Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized phase III trial studies bevacizumab and intravenous (given into a vein)
      chemotherapy to see how well they work compared with bevacizumab and intraperitoneal (given
      into the abdominal cavity) chemotherapy in treating patients with stage II-III ovarian
      epithelial cancer, fallopian tube cancer, or primary peritoneal cancer. Monoclonal
      antibodies, such as bevacizumab, can block the ability of tumor cells to grow and spread by
      blocking the growth of new blood vessels necessary for tumor growth. Drugs used in
      chemotherapy, such as paclitaxel, carboplatin, and cisplatin, work in different ways to stop
      the growth of tumor cells, either by killing the cells or by stopping them from dividing. It
      is not yet known whether giving bevacizumab together with intravenous chemotherapy is more
      effective than giving bevacizumab together with intraperitoneal chemotherapy in treating
      patients with ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      I. To determine if one or both of the proposed intraperitoneal chemotherapy regimens improves
      the progression-free survival (PFS) event rate compared to standard intravenous chemotherapy
      for first-line treatment of patients diagnosed with advanced stage ovarian, peritoneal or
      fallopian tube cancer.

      II. If both intraperitoneal (IP) regimens significantly improve the PFS event rate compared
      to the standard regimen, then a second study objective is to determine whether IP cisplatin
      and intravenous (IV) paclitaxel on day one plus IP paclitaxel on day eight improves the PFS
      event rate when compared to the IP carboplatin and IV paclitaxel.

      SECONDARY OBJECTIVES:

      I. To determine if intraperitoneal chemotherapy reduces the overall death rate compared to
      standard intravenous chemotherapy.

      II. To assess the frequency and severity of adverse events as defined by Common Terminology
      Criteria for Adverse Events (CTCAE) version 3.0.

      III. To compare the patient-reported outcomes on: Quality of Life (Function Assessment of
      Cancer Therapy-Ovarian-Trial Outcome Index [FACT-O-TOI]), Neuropathy (FACT-Gynecologic
      Oncology Group/Neurotoxicity [GOG/NTX4] scale), Abdominal discomfort (FACT-GOG/AD scale),
      Fatigue (FACIT-Fatigue scale), and Nausea (item from FACT-O-TOI).

      IV. To assess the frequency and the reasons for early discontinuation of the study
      treatments.

      TERTIARY OBJECTIVES:

      I. To bank deoxyribonucleic acid (DNA) from whole blood for research and examine the
      association between single nucleotide polymorphisms (SNPs) and measures of clinical outcome
      including overall survival, progression-free survival and adverse events.

      II. To bank archival tumor for research and examine the association between tumor markers and
      measures of clinical outcome including overall survival, progression-free survival and
      adverse events.

      III. Patients will be encouraged to enroll on the companion translational research protocol
      (CEM0703 under development).

      OUTLINE: Patients are randomized to 1 of 3 treatment arms.

      ARM I: Patients receive paclitaxel IV over 1 hour on days 1, 8, and 15 and carboplatin IV
      over 30 minutes on day 1. Patients also receive bevacizumab IV over 30-90 minutes on day 1 in
      courses 2-6. Treatment repeats every 21 days for 6 courses in the absence of disease
      progression or unacceptable toxicity. Patients then receive bevacizumab alone in courses 7-22
      in the absence of disease progression or unacceptable toxicity.

      ARM II: Patients receive paclitaxel as in Arm I and carboplatin IP on day 1. Patients also
      receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence
      of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as
      in Arm I.

      ARM III: Patients receive paclitaxel IV over 3 hours on day 1, cisplatin IP on day 2, and
      paclitaxel IP on day 8. Patients also receive bevacizumab as in Arm I. Treatment repeats
      every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity.
      Patients then receive bevacizumab alone as in Arm I.

      After completion of study treatment, patients are followed up every 3 months for 2 years,
      every 6 months for 3 years, and then annually for 5 years.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">March 15, 2022</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Median Progression-free Survival</measure>
    <time_frame>Progression-free survival is measured from date of randomization until first indication of progression based on RECIST criteria or death from any cause, or if progression-free at last contact, the date of last disease assessment up to 10 years.</time_frame>
    <description>Estimate the median duration of progression-free survival in months. Progression is defined using Response Evaluation Criteria in Solid Tumors criteria (RECIST v1.0) as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients With Adverse Events by Treatment Group, as Defined by NCI CTCAE (Common Terminology Criteria for Adverse Events Version 3.0) Version 3.0</measure>
    <time_frame>During treatment and up to 30 days after end of treatment</time_frame>
    <description>Eligible and treated patients. CTCAE includes grades 1-5. Grade refers to the severity of the adverse event. Grades 0 listed should be interpreted to mean there were no subjects in the arm with a toxicity to report. Grade 1 toxicities are mild; asymptomatic or mild symptoms. Grade 2 toxicities are moderate; minimal, local or noninvasive intervention indicated. Grade 3 toxicities are severe or medically significant but not immediately life-threatening. Grade 4 toxicities are life threatening. Grade 5 is death related to adverse event.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Estimate the median duration of overall survival in months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Quality of Life (QOL)</measure>
    <time_frame>Time points: Baseline, prior to cycle 4, prior to cycle 7, prior to cycle 13, prior to cycle 21, up to 84 weeks post starting treatment</time_frame>
    <description>QOL was measured with the FACT-O TOI score. Means at baseline are raw means. Scores are reported at all time points in the outcome measure table. FACT-O TOI is Trial outcome index (TOI) of the Functional assessment of cancer therapy (FACT) for ovarian cancer (FACT-O). The FACT-O TOI is composed of three subscales; Physical Well Being (PWB) ( 7 items), and Ovarian Cancer subscale (OCS) (12 items). Each item in the FACT-O TOI are scored using a 5 point scale (0=not at all; 1=a little bit; 2=somewhat;3=quite a bit;4=very much). A subscale score is computed as long as more thatn 50% of subscale items have been answered. A total score of the FACT-O items provide valid responses and all three subscales have valid scores. A score of the FACT-) TOI is ranged 0-104 with a larger score indicating a more preferred state of health-related quality of life (HRQOL).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Neurotoxicity (Ntx)</measure>
    <time_frame>Time points: Baseline, prior to cycle 4, prior to cycle 7, prior to cycle 13, prior to cycle 21, 84 weeks post starting treatment</time_frame>
    <description>The FACT/GOG-NTX subscale (short version) contains 4 items measuring sensory neuropathy. Each item is scored using a 5 point Likert scale (0=not at all; 1=a little bit;2=somewhat;3=quite a bit; 4=very much). For each item, reversal was performed prior to score calculation so that a large score suggests less symptoms. According to the FACIT measurement system, the subscale score was calculated as the summation of the individual item scores if more than 50% of a subscale items were answered. When unanswered items existed, a subscale score was prorated by multiplying the mean of the answered item scores by the number of items in the subscale. The Ntx subscale score ranges from 0-16 with a large subscale score suggesting less symptom or better QOL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Fatigue</measure>
    <time_frame>Time points: Baseline, prior to cycle 4, prior to cycle 7, prior to cycle 13, prior to cycle 21, 84 weeks post starting treatment</time_frame>
    <description>Patient reported fatigue as measured with the Functional Assessment of Chronic Illness Therapy- Fatigue scale (FACIT-Fatigue). The FACIT-Fatigue contains 13 items. Each item was scored using a 5-point scale (0=not at all; 1=a little bit; 2=somewhat; 3=quite a bit; 4=very much). For the negative items, reversal was performed prior to score calculation. According to the FACIT measurement system, the Fatigue score was the summation of the individual item scores if more than 50% of subscale items were answered. When unanswered items existed, a subscale score was prorated by multiplying the mean of the answered item scores by the number of items in the scale. The FACIT-Fatigue score ranges 0-52 with a large score suggesting less fatigue.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Nausea</measure>
    <time_frame>Time points: Baseline, prior to cycle 4, prior to cycle 7, prior to cycle 13, prior to cycle 21, 84 weeks post starting treatment</time_frame>
    <description>Nausea was measured with the a single item ,' I have nausea' from the FACT-O TOI</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">1560</enrollment>
  <condition>Malignant Ovarian Mixed Epithelial Tumor</condition>
  <condition>Ovarian Brenner Tumor</condition>
  <condition>Ovarian Clear Cell Cystadenocarcinoma</condition>
  <condition>Ovarian Endometrioid Adenocarcinoma</condition>
  <condition>Ovarian Mucinous Cystadenocarcinoma</condition>
  <condition>Ovarian Serous Cystadenocarcinoma</condition>
  <condition>Stage IIA Fallopian Tube Cancer</condition>
  <condition>Stage IIA Ovarian Cancer</condition>
  <condition>Stage IIB Fallopian Tube Cancer</condition>
  <condition>Stage IIB Ovarian Cancer</condition>
  <condition>Stage IIC Fallopian Tube Cancer</condition>
  <condition>Stage IIC Ovarian Cancer</condition>
  <condition>Stage IIIA Fallopian Tube Cancer</condition>
  <condition>Stage IIIA Ovarian Cancer</condition>
  <condition>Stage IIIA Primary Peritoneal Cancer</condition>
  <condition>Stage IIIB Fallopian Tube Cancer</condition>
  <condition>Stage IIIB Ovarian Cancer</condition>
  <condition>Stage IIIB Primary Peritoneal Cancer</condition>
  <condition>Stage IIIC Fallopian Tube Cancer</condition>
  <condition>Stage IIIC Ovarian Cancer</condition>
  <condition>Stage IIIC Primary Peritoneal Cancer</condition>
  <condition>Undifferentiated Ovarian Carcinoma</condition>
  <arm_group>
    <arm_group_label>Arm I (paclitaxel, carboplatin, bevacizumab)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive paclitaxel IV over 1 hour on days 1, 8, and 15 and carboplatin IV over 30 minutes on day 1. Patients also receive bevacizumab IV over 30-90 minutes on day 1 in courses 2-6. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone in courses 7-22 in the absence of disease progression or unacceptable toxicity.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II (paclitaxel, bevacizumab, carboplatin IP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive paclitaxel as in Arm I and carboplatin IP on day 1. Patients also receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as in Arm I.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm III (paclitaxel IP, bevacizumab, cisplatin IP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive paclitaxel IV over 3 hours on day 1, cisplatin IP on day 2, and paclitaxel IP on day 8. Patients also receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as in Arm I.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Bevacizumab</intervention_name>
    <description>Given IV</description>
    <arm_group_label>Arm I (paclitaxel, carboplatin, bevacizumab)</arm_group_label>
    <arm_group_label>Arm II (paclitaxel, bevacizumab, carboplatin IP)</arm_group_label>
    <arm_group_label>Arm III (paclitaxel IP, bevacizumab, cisplatin IP)</arm_group_label>
    <other_name>Anti-VEGF</other_name>
    <other_name>Anti-VEGF Humanized Monoclonal Antibody</other_name>
    <other_name>Anti-VEGF rhuMAb</other_name>
    <other_name>Avastin</other_name>
    <other_name>Bevacizumab Biosimilar BEVZ92</other_name>
    <other_name>Bevacizumab Biosimilar BI 695502</other_name>
    <other_name>Immunoglobulin G1 (Human-Mouse Monoclonal rhuMab-VEGF Gamma-Chain Anti-Human Vascular Endothelial Growth Factor), Disulfide With Human-Mouse Monoclonal rhuMab-VEGF Light Chain, Dimer</other_name>
    <other_name>Recombinant Humanized Anti-VEGF Monoclonal Antibody</other_name>
    <other_name>rhuMab-VEGF</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Carboplatin</intervention_name>
    <description>Given IV</description>
    <arm_group_label>Arm I (paclitaxel, carboplatin, bevacizumab)</arm_group_label>
    <other_name>Blastocarb</other_name>
    <other_name>Carboplat</other_name>
    <other_name>Carboplatin Hexal</other_name>
    <other_name>Carboplatino</other_name>
    <other_name>Carbosin</other_name>
    <other_name>Carbosol</other_name>
    <other_name>Carbotec</other_name>
    <other_name>CBDCA</other_name>
    <other_name>Displata</other_name>
    <other_name>Ercar</other_name>
    <other_name>JM-8</other_name>
    <other_name>Nealorin</other_name>
    <other_name>Novoplatinum</other_name>
    <other_name>Paraplat</other_name>
    <other_name>Paraplatin</other_name>
    <other_name>Paraplatin AQ</other_name>
    <other_name>Paraplatine</other_name>
    <other_name>Platinwas</other_name>
    <other_name>Ribocarbo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Carboplatin</intervention_name>
    <description>Given IP</description>
    <arm_group_label>Arm II (paclitaxel, bevacizumab, carboplatin IP)</arm_group_label>
    <other_name>Blastocarb</other_name>
    <other_name>Carboplat</other_name>
    <other_name>Carboplatin Hexal</other_name>
    <other_name>Carboplatino</other_name>
    <other_name>Carbosin</other_name>
    <other_name>Carbosol</other_name>
    <other_name>Carbotec</other_name>
    <other_name>CBDCA</other_name>
    <other_name>Displata</other_name>
    <other_name>Ercar</other_name>
    <other_name>JM-8</other_name>
    <other_name>Nealorin</other_name>
    <other_name>Novoplatinum</other_name>
    <other_name>Paraplat</other_name>
    <other_name>Paraplatin</other_name>
    <other_name>Paraplatin AQ</other_name>
    <other_name>Paraplatine</other_name>
    <other_name>Platinwas</other_name>
    <other_name>Ribocarbo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cisplatin</intervention_name>
    <description>Given IP</description>
    <arm_group_label>Arm III (paclitaxel IP, bevacizumab, cisplatin IP)</arm_group_label>
    <other_name>Abiplatin</other_name>
    <other_name>Blastolem</other_name>
    <other_name>Briplatin</other_name>
    <other_name>CDDP</other_name>
    <other_name>Cis-diammine-dichloroplatinum</other_name>
    <other_name>Cis-diamminedichloridoplatinum</other_name>
    <other_name>Cis-diamminedichloro Platinum (II)</other_name>
    <other_name>Cis-diamminedichloroplatinum</other_name>
    <other_name>Cis-dichloroammine Platinum (II)</other_name>
    <other_name>Cis-platinous Diamine Dichloride</other_name>
    <other_name>Cis-platinum</other_name>
    <other_name>Cis-platinum II</other_name>
    <other_name>Cis-platinum II Diamine Dichloride</other_name>
    <other_name>Cismaplat</other_name>
    <other_name>Cisplatina</other_name>
    <other_name>Cisplatinum</other_name>
    <other_name>Cisplatyl</other_name>
    <other_name>Citoplatino</other_name>
    <other_name>Citosin</other_name>
    <other_name>Cysplatyna</other_name>
    <other_name>DDP</other_name>
    <other_name>Lederplatin</other_name>
    <other_name>Metaplatin</other_name>
    <other_name>Neoplatin</other_name>
    <other_name>Peyrone's Chloride</other_name>
    <other_name>Peyrone's Salt</other_name>
    <other_name>Placis</other_name>
    <other_name>Plastistil</other_name>
    <other_name>Platamine</other_name>
    <other_name>Platiblastin</other_name>
    <other_name>Platiblastin-S</other_name>
    <other_name>Platinex</other_name>
    <other_name>Platinol</other_name>
    <other_name>Platinol- AQ</other_name>
    <other_name>Platinol-AQ</other_name>
    <other_name>Platinol-AQ VHA Plus</other_name>
    <other_name>Platinoxan</other_name>
    <other_name>Platinum</other_name>
    <other_name>Platinum Diamminodichloride</other_name>
    <other_name>Platiran</other_name>
    <other_name>Platistin</other_name>
    <other_name>Platosin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory Biomarker Analysis</intervention_name>
    <description>Correlative studies</description>
    <arm_group_label>Arm I (paclitaxel, carboplatin, bevacizumab)</arm_group_label>
    <arm_group_label>Arm II (paclitaxel, bevacizumab, carboplatin IP)</arm_group_label>
    <arm_group_label>Arm III (paclitaxel IP, bevacizumab, cisplatin IP)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paclitaxel</intervention_name>
    <description>Given IV</description>
    <arm_group_label>Arm I (paclitaxel, carboplatin, bevacizumab)</arm_group_label>
    <arm_group_label>Arm II (paclitaxel, bevacizumab, carboplatin IP)</arm_group_label>
    <arm_group_label>Arm III (paclitaxel IP, bevacizumab, cisplatin IP)</arm_group_label>
    <other_name>Anzatax</other_name>
    <other_name>Asotax</other_name>
    <other_name>Bristaxol</other_name>
    <other_name>Praxel</other_name>
    <other_name>Taxol</other_name>
    <other_name>Taxol Konzentrat</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paclitaxel</intervention_name>
    <description>Given IP</description>
    <arm_group_label>Arm III (paclitaxel IP, bevacizumab, cisplatin IP)</arm_group_label>
    <other_name>Anzatax</other_name>
    <other_name>Asotax</other_name>
    <other_name>Bristaxol</other_name>
    <other_name>Praxel</other_name>
    <other_name>Taxol</other_name>
    <other_name>Taxol Konzentrat</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality-of-Life Assessment</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I (paclitaxel, carboplatin, bevacizumab)</arm_group_label>
    <arm_group_label>Arm II (paclitaxel, bevacizumab, carboplatin IP)</arm_group_label>
    <arm_group_label>Arm III (paclitaxel IP, bevacizumab, cisplatin IP)</arm_group_label>
    <other_name>Quality of Life Assessment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a histologic diagnosis of epithelial ovarian, fallopian tube, or primary
             peritoneal carcinoma, stage II, III, or IV with either optimal (=&lt; 1 cm residual
             disease) or suboptimal residual disease; in the event of a higher priority Phase III
             Gynecologic Oncology Group (GOG) protocol becoming available for suboptimal and/or
             stage IV patients, the eligibility of this study will narrow and exclude those
             patients at those participating institutions (11/02/2009)

               -  Note: patients with suboptimal disease/and or stage IV will not be eligible as of
                  April 1, 2011; they should be enrolled on GOG-0262 (03/14/11)

               -  All patients must have a procedure for determining diagnosis of epithelial
                  ovarian, fallopian tube, primary peritoneal, with appropriate tissue for
                  histologic evaluation; the minimum surgery required is an abdominal surgery
                  providing tissue for histologic evaluation and establishing and documenting the
                  primary site and stage, as well as a maximal effort at tumor debulking; if
                  additional surgery was performed, it should have been in accordance with
                  appropriate surgery for ovarian or peritoneal carcinoma described in the GOG
                  Surgical Procedures Manual (https://www.gog.fccc.edu/manuals/pdf/surgman.pdf)
                  (11/02/2009)(08/16/2010)

          -  Patients with the following histologic epithelial cell types are eligible: serous
             adenocarcinoma, endometrioid adenocarcinoma, mucinous adenocarcinoma, undifferentiated
             carcinoma, clear cell adenocarcinoma, mixed epithelial carcinoma, transitional cell
             carcinoma, malignant Brenner's Tumor, or adenocarcinoma not otherwise specified
             (N.O.S.); however, the histologic features of the tumor must be compatible with a
             primary MÃ¼llerian epithelial adenocarcinoma; if doubt exists, it is recommended that
             the investigator should have the slides reviewed by an independent pathologist prior
             to entry; patients may have co-existing endometrial cancer so long as the primary
             origin of invasive tumor is ovarian or peritoneal; Note: patients with mucinous, low
             grade and clear cell disease are eligible unless there is a higher priority GOG trial
             open (11/02/2009) (08/16/2010)

          -  Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl, equivalent to
             Common Terminology Criteria for Adverse Events v3.0 (CTCAE) grade 1; this ANC cannot
             have been induced or supported by granulocyte colony stimulating factors

          -  Platelets greater than or equal to 100,000/mcl

          -  Creatinine no greater than institutional upper limits of normal (03/29/10)

          -  Bilirubin less than or equal to 1.5 x upper limit of normal (ULN) (CTCAE grade 1)

          -  Alanine aminotransferase (ALT), aspartate aminotransferase (AST) less than or equal to
             2.5 x ULN (CTCAE grade 1)

          -  Alkaline phosphatase less than or equal to 2.5 x ULN (CTCAE grade 1)

          -  Neuropathy (sensory and motor) less than or equal to CTCAE grade 1

          -  Prothrombin time (PT) such that international normalized ratio (INR) is =&lt; 1.5 x ULN
             (or an in-range INR, usually between 2 and 3, if a patient is on a stable dose of
             therapeutic warfarin) and a partial thromboplastin time (PTT) =&lt; 1.5 times the upper
             limit of normal (heparin, Lovenox or alternative anticoagulants are acceptable); this
             corresponds to CTCAE version 3.0 grade 1 one or less (11/02/2009) (03/29/10)

          -  Patients with a GOG performance status of 0, 1, or 2

          -  Patients must be entered and treated within 12 weeks of their most recent surgery
             performed for the combined purpose of diagnosis, staging and/or cytoreduction; the
             first cycle of chemotherapy should not be given until at least seven days after the
             most recent major surgery, which allows 4 weeks to have elapsed prior to the first
             bevacizumab dose; (placement of venous or peritoneal access devices will be considered
             minor surgery) (03/29/10)

          -  Patients who have met the pre-entry requirements specified

          -  An approved informed consent and authorization permitting release of personal health
             information must be signed by the patient or guardian

          -  Patients in this trial may receive ovarian estrogen +/- progestin replacement therapy
             as indicated at the lowest effective dose(s) for control of menopausal symptoms at any
             time, but high dose progestin as an appetite stimulant should be avoided (03/29/10)

        Exclusion Criteria:

          -  Patients with a current diagnosis of borderline epithelial ovarian tumor (formerly
             &quot;tumors of low malignant potential&quot;) or recurrent invasive epithelial ovarian cancer
             treated with surgery only (such as those with stage IA or IB low grade lesions) are
             not eligible; patients with a prior diagnosis of a borderline tumor that was
             surgically resected and who subsequently develop an unrelated, new invasive epithelial
             ovarian or peritoneal primary cancer are eligible, provided that they have not
             received prior chemotherapy for any ovarian tumor

          -  Patients with a history of other invasive malignancies, with the exception of
             non-melanoma skin cancer and other specific malignancies are excluded if there is any
             evidence of the other malignancy being present within the last five years; patients
             are also excluded if their previous cancer treatment contraindicates this protocol
             therapy (11/02/2009)

          -  Patients who have received prior radiotherapy to any portion of the abdominal cavity
             or pelvis are excluded; prior radiation for localized cancer of the breast, head and
             neck, or skin is permitted, provided that it was completed more than three years prior
             to registration, and the patient remains free of recurrent or metastatic disease

          -  Patients who have received prior chemotherapy for any abdominal or pelvic tumor
             including neo-adjuvant chemotherapy for their ovarian or primary peritoneal cancer are
             excluded; patients may have received prior adjuvant chemotherapy for localized breast
             cancer, provided that it was completed more than three years prior to registration,
             and that the patient remains free of recurrent or metastatic disease

          -  Patients who have received any targeted therapy (including but not limited to
             vaccines, antibodies, tyrosine kinase inhibitors) or hormonal therapy for management
             of their epithelial ovarian or peritoneal primary cancer

          -  Patients with synchronous primary endometrial cancer, or a past history of primary
             endometrial cancer, are excluded, unless all of the following conditions are met:
             stage not greater than IB; no more than superficial myometrial invasion, without
             vascular or lymphatic invasion; no poorly differentiated subtypes, including papillary
             serous, clear cell or other FIGO grade 3 lesions

          -  Patients with acute hepatitis or active infection that requires parenteral antibiotics

          -  Patients with serious non-healing wound, ulcer, or bone fracture; this includes
             history of abdominal fistula, gastrointestinal perforation or intra-abdominal abscess
             within 28 days; patients with granulating incisions healing by secondary intention
             with no evidence of fascial dehiscence or infection are eligible but require weekly
             wound examinations

          -  Patients with active bleeding or pathologic conditions that carry high risk of
             bleeding, such as known bleeding disorder, coagulopathy, or tumor involving major
             vessels

          -  Patients with history or evidence upon physical examination of major central nervous
             system (CNS) disease (for example: primary brain tumor, metastatic cancer in the
             brain, seizures not controlled with standard medical therapy, any brain metastases, or
             history of cerebrovascular accident [CVA, stroke], transient ischemic attack [TIA] or
             subarachnoid hemorrhage within six months of the first date of treatment on this
             study) (11/02/2009) (03/29/10)

          -  Patients with clinically significant cardiovascular disease; this includes:

               -  Uncontrolled hypertension, defined as systolic &gt; 150 mm Hg or diastolic &gt; 90 mmHg

               -  Myocardial infarction or unstable angina &lt; 6 months prior to registration

               -  New York Heart Association (NYHA) grade II or greater congestive heart failure

               -  Serious cardiac arrhythmia requiring medication; this does not include
                  asymptomatic atrial fibrillation with controlled ventricular rate, or past
                  history of supraventricular tachycardia controlled with medications and that is
                  asymptomatic (03/29/10)

               -  CTCAE grade 2 or greater peripheral vascular disease (at least brief (&lt; 24 hrs)
                  episodes of ischemia managed non-surgically and without permanent deficit)

          -  Patients with known hypersensitivity to Chinese hamster ovary cell products or other
             recombinant human or humanized antibodies; patients with known allergy to Cremophor or
             polysorbate 80

          -  Patients with clinically significant proteinuria; urine protein should be screened by
             urine protein-creatinine ratio (UPCR); patients must have a UPCR &lt; 1.0 to allow
             participation in the study

          -  Patients with or with anticipation of invasive procedures as defined below:

               -  Major surgical procedure, open biopsy or significant traumatic injury within 28
                  days prior to the first date of bevacizumab therapy (cycle 2)

               -  Major surgical procedure anticipated during the course of the study; this
                  includes, but is not limited to abdominal surgery (laparotomy or laparoscopy)
                  prior to disease progression, such as colostomy or enterostomy reversal, interval
                  or secondary cytoreductive surgery, or second look surgery

               -  Core biopsy, within 7 days prior to the first date of bevacizumab therapy (cycle
                  2)

          -  Patients with GOG performance grade of 3 or 4

          -  Patients who are pregnant or nursing; patients of childbearing potential must agree to
             use contraceptive measures during study therapy and for at least six months after
             completion of bevacizumab therapy

          -  Patients who have received prior therapy with any anti-vascular endothelial growth
             factor (VEGF) drug, including bevacizumab

          -  Patients with clinical symptoms or signs of gastrointestinal obstruction and/ or those
             who require parenteral hydration and/or nutrition; patients with history or current
             diagnosis of inflammatory bowel disease are not eligible (12/20/10)

          -  Patients with medical history or conditions not otherwise previously specified which
             in the opinion of the investigator should exclude participation in this study;
             examples of this would be: persistent gastrointestinal symptoms resulting from
             clostridia difficile enterocolitis or bowel surgery which may increase
             gastrointestinal toxicity from bevacizumab; or hearing loss or neuropathy which would
             prevent tolerance to cisplatin, and paclitaxel administration; the investigator should
             feel free to consult the Study Chair or Study Co-Chairs for uncertainty in this regard
             (12/20/10)

          -  Patients with metastatic tumor in the parenchyma of the liver or lungs with proximity
             to large vessels which could make the patient as high risk of lethal hemorrhage during
             treatment with bevacizumab (i.e. hemoptysis, liver rupture) (11/02/2009)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joan Walker</last_name>
    <role>Principal Investigator</role>
    <affiliation>NRG Oncology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham Cancer Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of South Alabama Mitchell Cancer Institute</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36688</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Alaska Medical Center</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Hospital and Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Arizona Cancer Center-North Campus</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85719</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alta Bates Summit Medical Center-Herrick Campus</name>
      <address>
        <city>Berkeley</city>
        <state>California</state>
        <zip>94704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Saint Joseph Medical Center/Disney Family Cancer Center</name>
      <address>
        <city>Burbank</city>
        <state>California</state>
        <zip>91505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mills - Peninsula Hospitals</name>
      <address>
        <city>Burlingame</city>
        <state>California</state>
        <zip>94010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Muir Medical Center-Concord Campus</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <zip>94520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City of Hope Comprehensive Cancer Center</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marin General Hospital</name>
      <address>
        <city>Greenbrae</city>
        <state>California</state>
        <zip>94904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center-Todd Cancer Institute</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCLA / Jonsson Comprehensive Cancer Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Palo Alto Medical Foundation-Gynecologic Oncology</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>94040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sutter Cancer Research Consortium</name>
      <address>
        <city>Novato</city>
        <state>California</state>
        <zip>94945</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Hospital - Orange</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UC Irvine Health/Chao Family Comprehensive Cancer Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford Cancer Institute</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PCR Oncology</name>
      <address>
        <city>Pismo Beach</city>
        <state>California</state>
        <zip>93449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sutter Roseville Medical Center</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95661</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sutter General Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California Davis Comprehensive Cancer Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSF Medical Center-Mount Zion</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center-Pacific Campus</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sutter Solano Medical Center/Cancer Center</name>
      <address>
        <city>Vallejo</city>
        <state>California</state>
        <zip>94589</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Muir Medical Center-Walnut Creek</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Colorado Gynecologic Oncology Group</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Cancer Center - Anschutz Cancer Pavilion</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Gynecologic Oncology PC</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Danbury Hospital</name>
      <address>
        <city>Danbury</city>
        <state>Connecticut</state>
        <zip>06810</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Smilow Cancer Hospital Care Center at Saint Francis</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Hospital of Central Connecticut</name>
      <address>
        <city>New Britain</city>
        <state>Connecticut</state>
        <zip>06050</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Connecticut Hematology and Oncology Associates</name>
      <address>
        <city>Norwich</city>
        <state>Connecticut</state>
        <zip>06360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stamford Hospital/Bennett Cancer Center</name>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <zip>06904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beebe Medical Center</name>
      <address>
        <city>Lewes</city>
        <state>Delaware</state>
        <zip>19958</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christiana Care Health System-Christiana Hospital</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sibley Memorial Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morton Plant Hospital</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Gynecologic Oncology</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Vincent's Medical Center</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southeast Gynecologic Oncology Associates</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224-9980</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Watson Clinic</name>
      <address>
        <city>Lakeland</city>
        <state>Florida</state>
        <zip>33805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami Miller School of Medicine-Sylvester Cancer Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Hospital Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UF Cancer Center at Orlando Health</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bayfront Outpatient Health Clinic</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's Cancer Associates</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northside Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John B Amos Cancer Center</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northeast Georgia Medical Center</name>
      <address>
        <city>Gainesville</city>
        <state>Georgia</state>
        <zip>30501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial University Medical Center</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pali Momi Medical Center</name>
      <address>
        <city>'Aiea</city>
        <state>Hawaii</state>
        <zip>96701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oncare Hawaii Inc-POB II</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen's Medical Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Straub Clinic and Hospital</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Hawaii Cancer Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oncare Hawaii Inc-Kuakini</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cancer Center of Hawaii-Liliha</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kapiolani Medical Center for Women and Children</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96826</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wilcox Memorial Hospital and Kauai Medical Clinic</name>
      <address>
        <city>Lihue</city>
        <state>Hawaii</state>
        <zip>96766</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maui Memorial Medical Center</name>
      <address>
        <city>Wailuku</city>
        <state>Hawaii</state>
        <zip>96793</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Cancer Institute of Maui</name>
      <address>
        <city>Wailuku</city>
        <state>Hawaii</state>
        <zip>96793</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kootenai Cancer Center</name>
      <address>
        <city>Post Falls</city>
        <state>Idaho</state>
        <zip>83854</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Medical Center</name>
      <address>
        <city>Bloomington</city>
        <state>Illinois</state>
        <zip>61701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Bloomington</name>
      <address>
        <city>Bloomington</city>
        <state>Illinois</state>
        <zip>61704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Graham Hospital Association</name>
      <address>
        <city>Canton</city>
        <state>Illinois</state>
        <zip>61520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Canton</name>
      <address>
        <city>Canton</city>
        <state>Illinois</state>
        <zip>61520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Carthage</name>
      <address>
        <city>Carthage</city>
        <state>Illinois</state>
        <zip>62321</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital</name>
      <address>
        <city>Carthage</city>
        <state>Illinois</state>
        <zip>62321</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Presence Resurrection Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60631</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago Comprehensive Cancer Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Decatur Memorial Hospital</name>
      <address>
        <city>Decatur</city>
        <state>Illinois</state>
        <zip>62526</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartland Cancer Research NCORP</name>
      <address>
        <city>Decatur</city>
        <state>Illinois</state>
        <zip>62526</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eureka Hospital</name>
      <address>
        <city>Eureka</city>
        <state>Illinois</state>
        <zip>61530</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Eureka</name>
      <address>
        <city>Eureka</city>
        <state>Illinois</state>
        <zip>61530</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NorthShore University HealthSystem-Evanston Hospital</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Galesburg Cottage Hospital</name>
      <address>
        <city>Galesburg</city>
        <state>Illinois</state>
        <zip>61401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Cottage</name>
      <address>
        <city>Galesburg</city>
        <state>Illinois</state>
        <zip>61401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Galesburg</name>
      <address>
        <city>Galesburg</city>
        <state>Illinois</state>
        <zip>61401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Havana</name>
      <address>
        <city>Havana</city>
        <state>Illinois</state>
        <zip>62644</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mason District Hospital</name>
      <address>
        <city>Havana</city>
        <state>Illinois</state>
        <zip>62644</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sudarshan K Sharma MD Limted-Gynecologic Oncology</name>
      <address>
        <city>Hinsdale</city>
        <state>Illinois</state>
        <zip>60521</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Kewanee Clinic</name>
      <address>
        <city>Kewanee</city>
        <state>Illinois</state>
        <zip>61443</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Macomb</name>
      <address>
        <city>Macomb</city>
        <state>Illinois</state>
        <zip>61455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mcdonough District Hospital</name>
      <address>
        <city>Macomb</city>
        <state>Illinois</state>
        <zip>61455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holy Family Medical Center</name>
      <address>
        <city>Monmouth</city>
        <state>Illinois</state>
        <zip>61462</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Monmouth</name>
      <address>
        <city>Monmouth</city>
        <state>Illinois</state>
        <zip>61462</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bromenn Regional Medical Center</name>
      <address>
        <city>Normal</city>
        <state>Illinois</state>
        <zip>61761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Cancer Center Foundation</name>
      <address>
        <city>Normal</city>
        <state>Illinois</state>
        <zip>61761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Community Cancer Center</name>
      <address>
        <city>Normal</city>
        <state>Illinois</state>
        <zip>61761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Ottawa Clinic</name>
      <address>
        <city>Ottawa</city>
        <state>Illinois</state>
        <zip>61350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ottawa Regional Hospital and Healthcare Center</name>
      <address>
        <city>Ottawa</city>
        <state>Illinois</state>
        <zip>61350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advocate Lutheran General Hospital</name>
      <address>
        <city>Park Ridge</city>
        <state>Illinois</state>
        <zip>60068</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Pekin</name>
      <address>
        <city>Pekin</city>
        <state>Illinois</state>
        <zip>61554</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center</name>
      <address>
        <city>Pekin</city>
        <state>Illinois</state>
        <zip>61554</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pekin Hospital</name>
      <address>
        <city>Pekin</city>
        <state>Illinois</state>
        <zip>61554</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Medical Center of Illinois</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61603</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Proctor Hospital</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Peoria</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OSF Saint Francis Medical Center</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Peru</name>
      <address>
        <city>Peru</city>
        <state>Illinois</state>
        <zip>61354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois Valley Hospital</name>
      <address>
        <city>Peru</city>
        <state>Illinois</state>
        <zip>61354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Princeton</name>
      <address>
        <city>Princeton</city>
        <state>Illinois</state>
        <zip>61356</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Perry Memorial Hospital</name>
      <address>
        <city>Princeton</city>
        <state>Illinois</state>
        <zip>61356</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Illinois CancerCare-Spring Valley</name>
      <address>
        <city>Spring Valley</city>
        <state>Illinois</state>
        <zip>61362</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Margaret's Hospital</name>
      <address>
        <city>Spring Valley</city>
        <state>Illinois</state>
        <zip>61362</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62781</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern Medicine Cancer Center Warrenville</name>
      <address>
        <city>Warrenville</city>
        <state>Illinois</state>
        <zip>60555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elkhart Clinic</name>
      <address>
        <city>Elkhart</city>
        <state>Indiana</state>
        <zip>46514-2098</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michiana Hematology Oncology PC-Elkhart</name>
      <address>
        <city>Elkhart</city>
        <state>Indiana</state>
        <zip>46514</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elkhart General Hospital</name>
      <address>
        <city>Elkhart</city>
        <state>Indiana</state>
        <zip>46515</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University/Melvin and Bren Simon Cancer Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Vincent Hospital and Health Care Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Vincent Oncology Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Howard Regional Health</name>
      <address>
        <city>Kokomo</city>
        <state>Indiana</state>
        <zip>46904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IU Health La Porte Hospital</name>
      <address>
        <city>La Porte</city>
        <state>Indiana</state>
        <zip>46350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michiana Hematology Oncology PC-Mishawaka</name>
      <address>
        <city>Mishawaka</city>
        <state>Indiana</state>
        <zip>46545</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Regional Medical Center-Mishawaka</name>
      <address>
        <city>Mishawaka</city>
        <state>Indiana</state>
        <zip>46545</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Community Hospital</name>
      <address>
        <city>Munster</city>
        <state>Indiana</state>
        <zip>46321</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michiana Hematology Oncology PC-Plymouth</name>
      <address>
        <city>Plymouth</city>
        <state>Indiana</state>
        <zip>46563</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reid Hospital and Health Care Services</name>
      <address>
        <city>Richmond</city>
        <state>Indiana</state>
        <zip>47374</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital of South Bend</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michiana Hematology Oncology PC-South Bend</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Bend Clinic</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46617</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern Indiana Cancer Research Consortium CCOP</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46628</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michiana Hematology Oncology PC-Westville</name>
      <address>
        <city>Westville</city>
        <state>Indiana</state>
        <zip>46391</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McFarland Clinic PC-William R Bliss Cancer Center</name>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <zip>50010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Oncology and Hematology Associates-West Des Moines</name>
      <address>
        <city>Clive</city>
        <state>Iowa</state>
        <zip>50325</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Capitol</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa Methodist Medical Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa-Wide Oncology Research Coalition NCORP</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Oncology and Hematology Associates-Des Moines</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Oncology and Hematology Associates-Laurel</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center - Des Moines</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa Lutheran Hospital</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50316</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa/Holden Comprehensive Cancer Center</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Chanute</name>
      <address>
        <city>Chanute</city>
        <state>Kansas</state>
        <zip>66720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Dodge City</name>
      <address>
        <city>Dodge City</city>
        <state>Kansas</state>
        <zip>67801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - El Dorado</name>
      <address>
        <city>El Dorado</city>
        <state>Kansas</state>
        <zip>67042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Fort Scott</name>
      <address>
        <city>Fort Scott</city>
        <state>Kansas</state>
        <zip>66701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas-Independence</name>
      <address>
        <city>Independence</city>
        <state>Kansas</state>
        <zip>67301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kansas Cancer Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas-Kingman</name>
      <address>
        <city>Kingman</city>
        <state>Kansas</state>
        <zip>67068</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lawrence Memorial Hospital</name>
      <address>
        <city>Lawrence</city>
        <state>Kansas</state>
        <zip>66044</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas-Liberal</name>
      <address>
        <city>Liberal</city>
        <state>Kansas</state>
        <zip>67901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Newton</name>
      <address>
        <city>Newton</city>
        <state>Kansas</state>
        <zip>67114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Parsons</name>
      <address>
        <city>Parsons</city>
        <state>Kansas</state>
        <zip>67357</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Pratt</name>
      <address>
        <city>Pratt</city>
        <state>Kansas</state>
        <zip>67124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Salina</name>
      <address>
        <city>Salina</city>
        <state>Kansas</state>
        <zip>67401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stormont-Vail Regional Health Center</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Wellington</name>
      <address>
        <city>Wellington</city>
        <state>Kansas</state>
        <zip>67152</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Associates In Womens Health</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas-Wichita Medical Arts Tower</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Main Office</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Via Christi Regional Medical Center</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wichita NCI Community Oncology Research Program</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Winfield</name>
      <address>
        <city>Winfield</city>
        <state>Kansas</state>
        <zip>67156</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Elizabeth Medical Center South</name>
      <address>
        <city>Edgewood</city>
        <state>Kentucky</state>
        <zip>41017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Health Lexington</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kentucky/Markey Cancer Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norton Hospital Pavilion and Medical Campus</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hematology/Oncology Clinic LLP</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70809</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Woman's Hospital</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tulane University Health Sciences Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center Jefferson</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harold Alfond Center for Cancer Care</name>
      <address>
        <city>Augusta</city>
        <state>Maine</state>
        <zip>04330</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Maine Medical Center</name>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <zip>04401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maine Medical Center-Bramhall Campus</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greater Baltimore Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sinai Hospital of Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Franklin Square Medical Center/Weinberg Cancer Institute</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21237</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University/Sidney Kimmel Cancer Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889-5600</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Union Hospital of Cecil County</name>
      <address>
        <city>Elkton</city>
        <state>Maryland</state>
        <zip>21921</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Associates in Oncology Hematology PC -Kensington</name>
      <address>
        <city>Kensington</city>
        <state>Maryland</state>
        <zip>20895</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maryland Oncology Hematology PA-Aquilino Cancer Center</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <zip>20850</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holy Cross Hospital</name>
      <address>
        <city>Silver Spring</city>
        <state>Maryland</state>
        <zip>20910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital Cancer Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dana-Farber/Harvard Cancer Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lahey Hospital and Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Commonwealth Hematology Oncology PC-Worcester</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Memorial Health Care</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Medical School</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Mercy Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106-0995</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan Cancer Research Consortium CCOP</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bronson Battle Creek</name>
      <address>
        <city>Battle Creek</city>
        <state>Michigan</state>
        <zip>49017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Big Rapids Hospital</name>
      <address>
        <city>Big Rapids</city>
        <state>Michigan</state>
        <zip>49307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oakwood Hospital and Medical Center</name>
      <address>
        <city>Dearborn</city>
        <state>Michigan</state>
        <zip>48124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne State University/Karmanos Cancer Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John Hospital and Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hurley Medical Center</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesys Regional Medical Center-West Flint Campus</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48532</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Research Consortium of West Michigan NCORP</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Health Saint Mary's</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health at Butterworth Campus</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gynecologic Oncology of West Michigan PLLC</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49546</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allegiance Health</name>
      <address>
        <city>Jackson</city>
        <state>Michigan</state>
        <zip>49201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Borgess Medical Center</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bronson Methodist Hospital</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Michigan Cancer Center</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sparrow Hospital</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Mary Mercy Hospital</name>
      <address>
        <city>Livonia</city>
        <state>Michigan</state>
        <zip>48154</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Health Mercy Campus</name>
      <address>
        <city>Muskegon</city>
        <state>Michigan</state>
        <zip>49444</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michiana Hematology Oncology PC-Niles</name>
      <address>
        <city>Niles</city>
        <state>Michigan</state>
        <zip>49120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Mercy Oakland</name>
      <address>
        <city>Pontiac</city>
        <state>Michigan</state>
        <zip>48341</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Mercy Port Huron</name>
      <address>
        <city>Port Huron</city>
        <state>Michigan</state>
        <zip>48060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital-Royal Oak</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Mary's of Michigan</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lakeland Hospital</name>
      <address>
        <city>Saint Joseph</city>
        <state>Michigan</state>
        <zip>49085</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marie Yeager Cancer Center</name>
      <address>
        <city>Saint Joseph</city>
        <state>Michigan</state>
        <zip>49085</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Hospital-Southfield Cancer Center</name>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <zip>48075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Munson Medical Center</name>
      <address>
        <city>Traverse City</city>
        <state>Michigan</state>
        <zip>49684</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John Macomb-Oakland Hospital</name>
      <address>
        <city>Warren</city>
        <state>Michigan</state>
        <zip>48093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metro Health Hospital</name>
      <address>
        <city>Wyoming</city>
        <state>Michigan</state>
        <zip>49519</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medini, Eitan MD (UIA Investigator)</name>
      <address>
        <city>Alexandria</city>
        <state>Minnesota</state>
        <zip>56308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Essentia Health Saint Joseph's Medical Center</name>
      <address>
        <city>Brainerd</city>
        <state>Minnesota</state>
        <zip>56401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fairview Ridges Hospital</name>
      <address>
        <city>Burnsville</city>
        <state>Minnesota</state>
        <zip>55337</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital</name>
      <address>
        <city>Coon Rapids</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Essentia Health Cancer Center</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Essentia Health Saint Mary's Medical Center</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miller-Dwan Hospital</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fairview-Southdale Hospital</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unity Hospital</name>
      <address>
        <city>Fridley</city>
        <state>Minnesota</state>
        <zip>55432</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hutchinson Area Health Care</name>
      <address>
        <city>Hutchinson</city>
        <state>Minnesota</state>
        <zip>55350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology Hematology PA-Maplewood</name>
      <address>
        <city>Maplewood</city>
        <state>Minnesota</state>
        <zip>55109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John's Hospital - Healtheast</name>
      <address>
        <city>Maplewood</city>
        <state>Minnesota</state>
        <zip>55109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abbott-Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hennepin County Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55415</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota/Masonic Cancer Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Memorial Medical Health Center</name>
      <address>
        <city>Robbinsdale</city>
        <state>Minnesota</state>
        <zip>55422</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coborn Cancer Center at Saint Cloud Hospital</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Cloud Hospital</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metro Minnesota Community Oncology Research Consortium</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Park Nicollet Clinic - Saint Louis Park</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Park Nicollet Frauenshuh Cancer Center</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55426</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regions Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Francis Regional Medical Center</name>
      <address>
        <city>Shakopee</city>
        <state>Minnesota</state>
        <zip>55379</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lakeview Hospital</name>
      <address>
        <city>Stillwater</city>
        <state>Minnesota</state>
        <zip>55082</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ridgeview Medical Center</name>
      <address>
        <city>Waconia</city>
        <state>Minnesota</state>
        <zip>55387</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rice Memorial Hospital</name>
      <address>
        <city>Willmar</city>
        <state>Minnesota</state>
        <zip>56201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology and Hematology PA-Woodbury</name>
      <address>
        <city>Woodbury</city>
        <state>Minnesota</state>
        <zip>55125</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Missouri - Ellis Fischel</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phelps County Regional Medical Center</name>
      <address>
        <city>Rolla</city>
        <state>Missouri</state>
        <zip>65401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Louis University Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Women's Oncology Center</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Research for the Ozarks NCORP</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital Springfield</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CoxHealth South Hospital</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montana Cancer Consortium NCORP</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern Rockies Radiation Oncology Center</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Vincent Healthcare</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frontier Cancer Center and Blood Institute-Billings</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Billings Clinic Cancer Center</name>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <zip>59107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bozeman Deaconess Cancer Center</name>
      <address>
        <city>Bozeman</city>
        <state>Montana</state>
        <zip>59715</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bozeman Deaconess Hospital</name>
      <address>
        <city>Bozeman</city>
        <state>Montana</state>
        <zip>59715</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint James Community Hospital and Cancer Treatment Center</name>
      <address>
        <city>Butte</city>
        <state>Montana</state>
        <zip>59701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Benefis Healthcare- Sletten Cancer Institute</name>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berdeaux, Donald MD (UIA Investigator)</name>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Big Sky Oncology</name>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Great Falls Clinic</name>
      <address>
        <city>Great Falls</city>
        <state>Montana</state>
        <zip>59405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern Montana Hospital</name>
      <address>
        <city>Havre</city>
        <state>Montana</state>
        <zip>59501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Peter's Community Hospital</name>
      <address>
        <city>Helena</city>
        <state>Montana</state>
        <zip>59601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glacier Oncology PLLC</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kalispell Medical Oncology</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kalispell Regional Medical Center</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Community Medical Hospital</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montana Cancer Specialists</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59802</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Patrick Hospital - Community Hospital</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59802</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guardian Oncology and Center for Wellness</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHI Health Good Samaritan</name>
      <address>
        <city>Kearney</city>
        <state>Nebraska</state>
        <zip>68847</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nebraska Methodist Hospital</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's Cancer Center of Nevada</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89169</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center of Hope at Renown Medical Center</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Renown Regional Medical Center</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norris Cotton Cancer Center-Manchester</name>
      <address>
        <city>Manchester</city>
        <state>New Hampshire</state>
        <zip>03102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cooper Hospital University Medical Center</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hunterdon Medical Center</name>
      <address>
        <city>Flemington</city>
        <state>New Jersey</state>
        <zip>08822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical CCOP</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virtua Memorial</name>
      <address>
        <city>Mount Holly</city>
        <state>New Jersey</state>
        <zip>08060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jersey Shore Medical Center</name>
      <address>
        <city>Neptune</city>
        <state>New Jersey</state>
        <zip>07753</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Hospital</name>
      <address>
        <city>Ridgewood</city>
        <state>New Jersey</state>
        <zip>07450</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Overlook Hospital</name>
      <address>
        <city>Summit</city>
        <state>New Jersey</state>
        <zip>07902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virtua Voorhees</name>
      <address>
        <city>Voorhees</city>
        <state>New Jersey</state>
        <zip>08043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southwest Gynecologic Oncology Associates Inc</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of New Mexico Cancer Center</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's Cancer Care Associates LLC</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Island Gynecologic Oncology</name>
      <address>
        <city>Brightwaters</city>
        <state>New York</state>
        <zip>11718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center-Einstein Campus</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Roswell Park Cancer Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Hospital Medical Center of Queens</name>
      <address>
        <city>Fresh Meadows</city>
        <state>New York</state>
        <zip>11365</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queens Hospital Center</name>
      <address>
        <city>Jamaica</city>
        <state>New York</state>
        <zip>11432</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore-LIJ Health System NCORP</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Long Island Jewish Medical Center</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore-LIJ Health System/Center for Advanced Medicine</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Laura and Isaac Perlmutter Cancer Center at NYU Langone</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan-Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Medical College of Cornell University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State University of New York Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Randolph Hospital</name>
      <address>
        <city>Asheboro</city>
        <state>North Carolina</state>
        <zip>27203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hope Women's Cancer Centers-Asheville</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cone Health Cancer Center at Alamance Regional</name>
      <address>
        <city>Burlington</city>
        <state>North Carolina</state>
        <zip>27216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UNC Lineberger Comprehensive Cancer Center</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center/Levine Cancer Institute</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cone Health Cancer Center</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke Raleigh Hospital</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Annie Penn Memorial Hospital</name>
      <address>
        <city>Reidsville</city>
        <state>North Carolina</state>
        <zip>27320</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Hanover Regional Medical Center/Zimmer Cancer Center</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southeast Clinical Oncology Research (SCOR) Consortium NCORP</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Summa Akron City Hospital/Cooper Cancer Center</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mary Rutan Hospital</name>
      <address>
        <city>Bellefontaine</city>
        <state>Ohio</state>
        <zip>43311</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aultman Health Foundation</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Adena Regional Medical Center</name>
      <address>
        <city>Chillicothe</city>
        <state>Ohio</state>
        <zip>45601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital - Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Case Western Reserve University</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MetroHealth Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Cancer Center/Fairview Hospital</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State University Comprehensive Cancer Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riverside Methodist Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbus NCI Community Oncology Research Program</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grant Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Carmel Health Center West</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43222</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Doctors Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43228</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grandview Hospital</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital - Dayton</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45406</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Valley Hospital</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45409</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samaritan North Health Center</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45415</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dayton NCI Community Oncology Research Program</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45420</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grady Memorial Hospital</name>
      <address>
        <city>Delaware</city>
        <state>Ohio</state>
        <zip>43015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Blanchard Valley Hospital</name>
      <address>
        <city>Findlay</city>
        <state>Ohio</state>
        <zip>45840</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atrium Medical Center-Middletown Regional Hospital</name>
      <address>
        <city>Franklin</city>
        <state>Ohio</state>
        <zip>45005-1066</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne Hospital</name>
      <address>
        <city>Greenville</city>
        <state>Ohio</state>
        <zip>45331</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kettering Medical Center</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fairfield Medical Center</name>
      <address>
        <city>Lancaster</city>
        <state>Ohio</state>
        <zip>43130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marietta Memorial Hospital</name>
      <address>
        <city>Marietta</city>
        <state>Ohio</state>
        <zip>45750</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hillcrest Hospital Cancer Center</name>
      <address>
        <city>Mayfield Heights</city>
        <state>Ohio</state>
        <zip>44124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lake University Ireland Cancer Center</name>
      <address>
        <city>Mentor</city>
        <state>Ohio</state>
        <zip>44060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Knox Community Hospital</name>
      <address>
        <city>Mount Vernon</city>
        <state>Ohio</state>
        <zip>43050</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Licking Memorial Hospital</name>
      <address>
        <city>Newark</city>
        <state>Ohio</state>
        <zip>43055</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Ohio Medical Center</name>
      <address>
        <city>Portsmouth</city>
        <state>Ohio</state>
        <zip>45662</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Springfield Regional Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Ohio</state>
        <zip>45505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Toledo</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Upper Valley Medical Center</name>
      <address>
        <city>Troy</city>
        <state>Ohio</state>
        <zip>45373</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Ann's Hospital</name>
      <address>
        <city>Westerville</city>
        <state>Ohio</state>
        <zip>43081</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinton Memorial Hospital</name>
      <address>
        <city>Wilmington</city>
        <state>Ohio</state>
        <zip>45177</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wright-Patterson Medical Center</name>
      <address>
        <city>Wright-Patterson Air Force Base</city>
        <state>Ohio</state>
        <zip>45433-5529</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greene Memorial Hospital</name>
      <address>
        <city>Xenia</city>
        <state>Ohio</state>
        <zip>45385</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesis Healthcare System Cancer Care Center</name>
      <address>
        <city>Zanesville</city>
        <state>Ohio</state>
        <zip>43701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Cancer Specialists and Research Institute-Tulsa</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74146</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Legacy Good Samaritan Hospital and Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Compass Oncology Rose Quarter</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abington Memorial Hospital</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <zip>19001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital-Cedar Crest</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luke's University Hospital-Bethlehem Campus</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center-Cancer Center Hazleton</name>
      <address>
        <city>Hazleton</city>
        <state>Pennsylvania</state>
        <zip>18201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn State Hershey Cancer Institute-Clinical Trials Office</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033-0850</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania/Abramson Cancer Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennsylvania Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fox Chase Cancer Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phoenixville Hospital</name>
      <address>
        <city>Phoenixville</city>
        <state>Pennsylvania</state>
        <zip>19460</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UPMC-Magee Womens Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Penn Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital</name>
      <address>
        <city>Scranton</city>
        <state>Pennsylvania</state>
        <zip>18501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scranton Hematology Oncology</name>
      <address>
        <city>Scranton</city>
        <state>Pennsylvania</state>
        <zip>18510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Group</name>
      <address>
        <city>State College</city>
        <state>Pennsylvania</state>
        <zip>16801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chester County Hospital</name>
      <address>
        <city>West Chester</city>
        <state>Pennsylvania</state>
        <zip>19380</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Wyoming Valley/Henry Cancer Center</name>
      <address>
        <city>Wilkes-Barre</city>
        <state>Pennsylvania</state>
        <zip>18711</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women and Infants Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AnMed Health Cancer Center</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Easley</name>
      <address>
        <city>Easley</city>
        <state>South Carolina</state>
        <zip>29640</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Francis Hospital</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Andrews</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Butternut</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Faris</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Memorial Hospital</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Eastside</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Self Regional Healthcare</name>
      <address>
        <city>Greenwood</city>
        <state>South Carolina</state>
        <zip>29646</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Centers of the Carolinas-Greer Medical Oncology</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29650</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Greer</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29650</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Seneca</name>
      <address>
        <city>Seneca</city>
        <state>South Carolina</state>
        <zip>29672</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spartanburg Medical Center</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Health System Cancer Institute-Spartanburg</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Black Hills Obstetrics and Gynecology</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanford Cancer Center-Oncology Clinic</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Avera Cancer Institute</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanford USD Medical Center - Sioux Falls</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57117-5134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Tennessee - Knoxville</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37920</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University/Ingram Cancer Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parkland Memorial Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zale Lipshy University Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clements University Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UT Southwestern/Simmons Cancer Center-Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brooke Army Medical Center</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor All Saints Medical Center at Fort Worth</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lyndon Baines Johnson General Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77026-1967</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Methodist Hospital System</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wilford Hall Medical Center</name>
      <address>
        <city>Lackland Air Force Base</city>
        <state>Texas</state>
        <zip>78236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scott and White Memorial Hospital</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McKay-Dee Hospital Center</name>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <zip>84403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Utah Valley Regional Medical Center</name>
      <address>
        <city>Provo</city>
        <state>Utah</state>
        <zip>84604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dixie Medical Center Regional Cancer Center</name>
      <address>
        <city>Saint George</city>
        <state>Utah</state>
        <zip>84770</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Intermountain Health Care</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huntsman Cancer Institute/University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LDS Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Vermont Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern Virginia Pelvic Surgery Associates</name>
      <address>
        <city>Annandale</city>
        <state>Virginia</state>
        <zip>22003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Cancer Center</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Danville Regional Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Virginia</state>
        <zip>24541</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peninsula Cancer Institute-Newport News</name>
      <address>
        <city>Newport News</city>
        <state>Virginia</state>
        <zip>23601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University/Massey Cancer Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carilion Clinic Gynecological Oncology</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PeaceHealth Medical Group PC</name>
      <address>
        <city>Bellingham</city>
        <state>Washington</state>
        <zip>98226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harrison HealthPartners Hematology and Oncology-Bremerton</name>
      <address>
        <city>Bremerton</city>
        <state>Washington</state>
        <zip>98310</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harrison Medical Center</name>
      <address>
        <city>Bremerton</city>
        <state>Washington</state>
        <zip>98310</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Regional Cancer Partnership</name>
      <address>
        <city>Everett</city>
        <state>Washington</state>
        <zip>98201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skagit Valley Hospital Regional Cancer Care Center</name>
      <address>
        <city>Mount Vernon</city>
        <state>Washington</state>
        <zip>98273</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harrison HealthPartners Hematology and Oncology-Poulsbo</name>
      <address>
        <city>Poulsbo</city>
        <state>Washington</state>
        <zip>98370</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Gynecology Specialists</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fred Hutchinson Cancer Research Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seattle Cancer Care Alliance</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Group Health Cooperative-Seattle</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center-First Hill</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122-4307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98133</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Olympic Medical Cancer Care Center</name>
      <address>
        <city>Sequim</city>
        <state>Washington</state>
        <zip>98384</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Care Northwest - Spokane South</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rockwood Cancer Treatment Center-DHEC-Downtown</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MultiCare Tacoma General Hospital</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Medical Center</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Saint Mary Regional Cancer Center</name>
      <address>
        <city>Walla Walla</city>
        <state>Washington</state>
        <zip>99362</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wenatchee Valley Hospital and Clinics</name>
      <address>
        <city>Wenatchee</city>
        <state>Washington</state>
        <zip>98801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cancer Institutes of Washington PLLC</name>
      <address>
        <city>Yakima</city>
        <state>Washington</state>
        <zip>98902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Star Lodge Cancer Center at Yakima Valley Memorial Hospital</name>
      <address>
        <city>Yakima</city>
        <state>Washington</state>
        <zip>98902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic-Chippewa Center</name>
      <address>
        <city>Chippewa Falls</city>
        <state>Wisconsin</state>
        <zip>54729</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic Cancer Center at Sacred Heart</name>
      <address>
        <city>Eau Claire</city>
        <state>Wisconsin</state>
        <zip>54701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Green Bay Oncology at Saint Vincent Hospital</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54301-3526</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Vincent Hospital</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Green Bay Oncology Limited at Saint Mary's Hospital</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Mary's Hospital</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora BayCare Medical Center</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54311-6519</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gundersen Lutheran Medical Center</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin Hospital and Clinics</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Hospital</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia Saint Mary's Hospital - Ozaukee</name>
      <address>
        <city>Mequon</city>
        <state>Wisconsin</state>
        <zip>53097</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia Saint Mary's Water Tower Medical Commons</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora Saint Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Froedtert and the Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora Sinai Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic-Minocqua Center</name>
      <address>
        <city>Minocqua</city>
        <state>Wisconsin</state>
        <zip>54548</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vince Lombardi Cancer Clinic - Oshkosh</name>
      <address>
        <city>Oshkosh</city>
        <state>Wisconsin</state>
        <zip>54904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic at James Beck Cancer Center</name>
      <address>
        <city>Rhinelander</city>
        <state>Wisconsin</state>
        <zip>54501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic-Rice Lake Center</name>
      <address>
        <city>Rice Lake</city>
        <state>Wisconsin</state>
        <zip>54868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic Cancer Care at Saint Michael's Hospital</name>
      <address>
        <city>Stevens Point</city>
        <state>Wisconsin</state>
        <zip>54481</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Michael's Hospital</name>
      <address>
        <city>Stevens Point</city>
        <state>Wisconsin</state>
        <zip>54481</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora Medical Center in Summit</name>
      <address>
        <city>Summit</city>
        <state>Wisconsin</state>
        <zip>53066</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vince Lombardi Cancer Clinic</name>
      <address>
        <city>Two Rivers</city>
        <state>Wisconsin</state>
        <zip>54241</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora West Allis Medical Center</name>
      <address>
        <city>West Allis</city>
        <state>Wisconsin</state>
        <zip>53227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic - Weston Center</name>
      <address>
        <city>Weston</city>
        <state>Wisconsin</state>
        <zip>54476</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic - Wisconsin Rapids Center</name>
      <address>
        <city>Wisconsin Rapids</city>
        <state>Wisconsin</state>
        <zip>54494</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Oncology</name>
      <address>
        <city>Casper</city>
        <state>Wyoming</state>
        <zip>82609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Welch Cancer Center</name>
      <address>
        <city>Sheridan</city>
        <state>Wyoming</state>
        <zip>82801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2009</study_first_submitted>
  <study_first_submitted_qc>August 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2009</study_first_posted>
  <results_first_submitted>October 4, 2017</results_first_submitted>
  <results_first_submitted_qc>April 19, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">May 18, 2018</results_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Fallopian Tube Neoplasms</mesh_term>
    <mesh_term>Peritoneal Neoplasms</mesh_term>
    <mesh_term>Cystadenocarcinoma</mesh_term>
    <mesh_term>Carcinoma, Endometrioid</mesh_term>
    <mesh_term>Cystadenocarcinoma, Serous</mesh_term>
    <mesh_term>Cystadenocarcinoma, Mucinous</mesh_term>
    <mesh_term>Brenner Tumor</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
    <mesh_term>Cisplatin</mesh_term>
    <mesh_term>Bevacizumab</mesh_term>
    <mesh_term>Carboplatin</mesh_term>
    <mesh_term>Endothelial Growth Factors</mesh_term>
    <mesh_term>Antibodies</mesh_term>
    <mesh_term>Immunoglobulins</mesh_term>
    <mesh_term>Antibodies, Monoclonal</mesh_term>
    <mesh_term>Immunoglobulin G</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study was opened for accrual on July 27, 2009. Target accrual was about 1500 patients. The study was closed to enrollment on Nov 30, 2011 after enrolling 1560 individuals.</recruitment_details>
      <pre_assignment_details>Eligibility was verified by a web-based procedure which reviewed all eligibility criteria prior to each subjectâs registration. Prior to treatment randomization patients were stratified by stage of disease and size of residual disease.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm I (Paclitaxel, Carboplatin, Bevcizumab IV)</title>
          <description>Six cycles of Paclitaxel 80mg/m2 IV over ` hours days 1, 8 and 15. Carboplatin AUC 6 IV on day 1, Bevacizumab 15mg/kg IV on day 1 beginning on cycle 2, followed by bevacizumab 15mg/kg for cycles 7-22.</description>
        </group>
        <group group_id="P2">
          <title>Arm II (Paclitaxel,carboplatinIP, Bevacizumab IP)</title>
          <description>Six cycles of Paclitaxel 80mg/m2 IV over 1 hour days 1, 8, and 15, Carboplatin AUC 6 IP on day1, Bevacizumab 15mg/kg IV on day 1 beginning on cycle 2 followed by bevacizumab 15mg/KG for cycles 7-22</description>
        </group>
        <group group_id="P3">
          <title>Arm III (Paclitaxel IP, Cisplatin, Bevacizumab)</title>
          <description>Six cycles of Paclitaxel 135 mg/m2 IV over 3 hours day 1, Cisplatin 75 mg/m2 IP on day 2, Paclitaxel 60 mg/m2 IP on day 8, Bevacizumab 15 mg/kg IV on day 1 beginning with cycle 2, followed by bevacizumab 15 mg/kg for cycles 7-22.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="521"/>
                <participants group_id="P2" count="518"/>
                <participants group_id="P3" count="521"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="511"/>
                <participants group_id="P2" count="510"/>
                <participants group_id="P3" count="508"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did not initiate study treatment</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm I (Paclitaxel, Carboplatin, Bevcizumab IV)</title>
          <description>Six cycles of Paclitaxel 80mg/m2 IV over ` hours days 1, 8 and 15. Carboplatin AUC 6 IV on day 1, Bevacizumab 15mg/kg IV on day 1 beginning on cycle 2, followed by bevacizumab 15mg/kg for cycles 7-22.</description>
        </group>
        <group group_id="B2">
          <title>Arm II (Paclitaxel,carboplatinIP, Bevacizumab IP)</title>
          <description>Six cycles of Paclitaxel 80mg/m2 IV over 1 hour days 1, 8, and 15, Carboplatin AUC 6 IP on day1, Bevacizumab 15mg/kg IV on day 1 beginning on cycle 2 followed by bevacizumab 15mg/KG for cycles 7-22</description>
        </group>
        <group group_id="B3">
          <title>Arm III (Paclitaxel IP, Cisplatin, Bevacizumab)</title>
          <description>Six cycles of Paclitaxel 135 mg/m2 IV over 3 hours day 1, Cisplatin 75 mg/m2 IP on day 2, Paclitaxel 60 mg/m2 IP on day 8, Bevacizumab 15 mg/kg IV on day 1 beginning with cycle 2, followed by bevacizumab 15 mg/kg for cycles 7-22.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="521"/>
            <count group_id="B2" value="518"/>
            <count group_id="B3" value="521"/>
            <count group_id="B4" value="1560"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>&lt;40 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>40 - 49 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="101"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="95"/>
                    <measurement group_id="B4" value="273"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>50 - 59 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="187"/>
                    <measurement group_id="B2" value="178"/>
                    <measurement group_id="B3" value="199"/>
                    <measurement group_id="B4" value="564"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 -69 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="152"/>
                    <measurement group_id="B2" value="181"/>
                    <measurement group_id="B3" value="151"/>
                    <measurement group_id="B4" value="484"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>70 - 79 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B3" value="53"/>
                    <measurement group_id="B4" value="168"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;79 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="521"/>
                    <measurement group_id="B2" value="518"/>
                    <measurement group_id="B3" value="521"/>
                    <measurement group_id="B4" value="1560"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="473"/>
                    <measurement group_id="B2" value="478"/>
                    <measurement group_id="B3" value="476"/>
                    <measurement group_id="B4" value="1427"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>FIGO Stage FIGO (International Federation of Gynecology &amp; Obstetrics) Staging</title>
          <description>FIGO staging of the Ovary was used. FIGO stage I includes all participants with disease confined to ovary. This stage has the best outcome, between 75 to 90% survival at 5 years. Stage II includes all participants with disease in ovaries and spread limited to pelvis (45 to 60% survival at 5 years). Stage III includes all participants with disease limited to abdomen. Stage IV disease includes all participants with distant metastasis outside the abdominal cavity. This stage has the worst outcome (&lt;20% survival at 5 years)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Stage I-II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="51"/>
                    <measurement group_id="B4" value="163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stage III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="441"/>
                    <measurement group_id="B2" value="432"/>
                    <measurement group_id="B3" value="432"/>
                    <measurement group_id="B4" value="1305"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stage IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="38"/>
                    <measurement group_id="B4" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Residual Disease Diameter</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Microscopic only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="297"/>
                    <measurement group_id="B2" value="297"/>
                    <measurement group_id="B3" value="305"/>
                    <measurement group_id="B4" value="899"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0 &lt; diameter &lt;= 1cm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="182"/>
                    <measurement group_id="B2" value="189"/>
                    <measurement group_id="B3" value="182"/>
                    <measurement group_id="B4" value="553"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 1cm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="34"/>
                    <measurement group_id="B4" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Histology/Grade of tumor</title>
          <description>The Histology/Grade lists how many participants entered the study with each type of tumor histology and the grade for the serous tumors. Histology is the type of tissue that the tumor is comprised of. The histologic types listed below include serous, endometrioid, clear cell, mucinous and other or not specified. Grading refers to (along with staging) describes the severity. Grade 1 tumor cells look a lot like normal ovarian cells. The outcome is good for grade I tumors. Grade 2 tumors are well differentiated. Grade 3 cells are more irregular and likely to metastasize.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Serous/Grade1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serous/Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="35"/>
                    <measurement group_id="B4" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serous/Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="370"/>
                    <measurement group_id="B2" value="379"/>
                    <measurement group_id="B3" value="377"/>
                    <measurement group_id="B4" value="1126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Endometrioid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clear Cell</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mucinous</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other/Not specified</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="47"/>
                    <measurement group_id="B4" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Median Progression-free Survival</title>
        <description>Estimate the median duration of progression-free survival in months. Progression is defined using Response Evaluation Criteria in Solid Tumors criteria (RECIST v1.0) as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions.</description>
        <time_frame>Progression-free survival is measured from date of randomization until first indication of progression based on RECIST criteria or death from any cause, or if progression-free at last contact, the date of last disease assessment up to 10 years.</time_frame>
        <population>Intention-to-treat: All enrolled patients</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Paclitaxel, Carboplatin, Bevcizumab IV)</title>
            <description>Six cycles of Paclitaxel 80mg/m2 IV over ` hours days 1, 8 and 15. Carboplatin AUC 6 IV on day 1, Bevacizumab 15mg/kg IV on day 1 beginning on cycle 2, followed by bevacizumab 15mg/kg for cycles 7-22.</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Paclitaxel,carboplatinIP, Bevacizumab IP)</title>
            <description>Six cycles of Paclitaxel 80mg/m2 IV over 1 hour days 1, 8, and 15, Carboplatin AUC 6 IP on day1, Bevacizumab 15mg/kg IV on day 1 beginning on cycle 2 followed by bevacizumab 15mg/KG for cycles 7-22</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Paclitaxel IP, Cisplatin, Bevacizumab)</title>
            <description>Six cycles of Paclitaxel 135 mg/m2 IV over 3 hours day 1, Cisplatin 75 mg/m2 IP on day 2, Paclitaxel 60 mg/m2 IP on day 8, Bevacizumab 15 mg/kg IV on day 1 beginning with cycle 2, followed by bevacizumab 15 mg/kg for cycles 7-22.</description>
          </group>
        </group_list>
        <measure>
          <title>Median Progression-free Survival</title>
          <description>Estimate the median duration of progression-free survival in months. Progression is defined using Response Evaluation Criteria in Solid Tumors criteria (RECIST v1.0) as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions.</description>
          <population>Intention-to-treat: All enrolled patients</population>
          <units>months</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="521"/>
                <count group_id="O2" value="518"/>
                <count group_id="O3" value="521"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.9" lower_limit="22.3" upper_limit="27.2"/>
                    <measurement group_id="O2" value="27.3" lower_limit="24.6" upper_limit="28.8"/>
                    <measurement group_id="O3" value="26.0" lower_limit="23.8" upper_limit="28.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>P value.(an P value is used to determine statistical significance in a hypothesis test). from a stratified log rank test to assess equality of progression free survival hazards of arm II and arm I</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Study was designed to provide 80% power when arm II reduces the progression free survival event rate 20%. The critical p-value accounts for correlation between 2 primary hypotheses.</non_inferiority_desc>
            <p_value>0.341</p_value>
            <p_value_desc>P value not adjusted for multiplicity. Significance Threshold = 0.027</p_value_desc>
            <method>Log Rank</method>
            <method_desc>Stratified by stage of disease and size of residual disease.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>1.09</ci_upper_limit>
            <estimate_desc>Progression free survival of arm II relative to arm I. Adjusted for stage of disease and residual size.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>P value from a log rank test comparing the progression free survival hazards of arm III to arm I.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Study was designed to provide 80% power when arm III reduced the true progression free survival event rate. 20% compared to arm I. Critical p value accounts for correlation between 2 primary hypotheses.</non_inferiority_desc>
            <p_value>0.587</p_value>
            <p_value_desc>P value not adjusted for multiplicity. Significance threshold = 0.027 accounting for 2 correlated primary hypotheses.</p_value_desc>
            <method>Log Rank</method>
            <method_desc>Stratified by stage of disease and size of residual disease.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.99</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.86</ci_lower_limit>
            <ci_upper_limit>1.15</ci_upper_limit>
            <estimate_desc>Progression free survival hazard of arm III to arm I. Adjusted for stage of disease and residual disease size.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patients With Adverse Events by Treatment Group, as Defined by NCI CTCAE (Common Terminology Criteria for Adverse Events Version 3.0) Version 3.0</title>
        <description>Eligible and treated patients. CTCAE includes grades 1-5. Grade refers to the severity of the adverse event. Grades 0 listed should be interpreted to mean there were no subjects in the arm with a toxicity to report. Grade 1 toxicities are mild; asymptomatic or mild symptoms. Grade 2 toxicities are moderate; minimal, local or noninvasive intervention indicated. Grade 3 toxicities are severe or medically significant but not immediately life-threatening. Grade 4 toxicities are life threatening. Grade 5 is death related to adverse event.</description>
        <time_frame>During treatment and up to 30 days after end of treatment</time_frame>
        <population>Treated Patients</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Paclitaxel, Carboplatin, Bevcizumab IV)</title>
            <description>Six cycles of Paclitaxel 80mg/m2 IV over ` hours days 1, 8 and 15. Carboplatin AUC 6 IV on day 1, Bevacizumab 15mg/kg IV on day 1 beginning on cycle 2, followed by bevacizumab 15mg/kg for cycles 7-22.</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Paclitaxel,carboplatinIP, Bevacizumab IP)</title>
            <description>Six cycles of Paclitaxel 80mg/m2 IV over 1 hour days 1, 8, and 15, Carboplatin AUC 6 IP on day1, Bevacizumab 15mg/kg IV on day 1 beginning on cycle 2 followed by bevacizumab 15mg/KG for cycles 7-22</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Paclitaxel IP, Cisplatin, Bevacizumab)</title>
            <description>Six cycles of Paclitaxel 135 mg/m2 IV over 3 hours day 1, Cisplatin 75 mg/m2 IP on day 2, Paclitaxel 60 mg/m2 IP on day 8, Bevacizumab 15 mg/kg IV on day 1 beginning with cycle 2, followed by bevacizumab 15 mg/kg for cycles 7-22.</description>
          </group>
        </group_list>
        <measure>
          <title>Patients With Adverse Events by Treatment Group, as Defined by NCI CTCAE (Common Terminology Criteria for Adverse Events Version 3.0) Version 3.0</title>
          <description>Eligible and treated patients. CTCAE includes grades 1-5. Grade refers to the severity of the adverse event. Grades 0 listed should be interpreted to mean there were no subjects in the arm with a toxicity to report. Grade 1 toxicities are mild; asymptomatic or mild symptoms. Grade 2 toxicities are moderate; minimal, local or noninvasive intervention indicated. Grade 3 toxicities are severe or medically significant but not immediately life-threatening. Grade 4 toxicities are life threatening. Grade 5 is death related to adverse event.</description>
          <population>Treated Patients</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="521"/>
                <count group_id="O2" value="518"/>
                <count group_id="O3" value="521"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adverse Event Grade 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adverse Event Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adverse Event Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                    <measurement group_id="O2" value="46"/>
                    <measurement group_id="O3" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adverse Event Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="269"/>
                    <measurement group_id="O2" value="300"/>
                    <measurement group_id="O3" value="246"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adverse Event Grade 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="185"/>
                    <measurement group_id="O2" value="158"/>
                    <measurement group_id="O3" value="199"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adverse Event Grade 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Survival</title>
        <description>Estimate the median duration of overall survival in months.</description>
        <time_frame>Up to 10 years</time_frame>
        <population>Intention-to-treat: All enrolled patients</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Paclitaxel, Carboplatin, Bevacizumab)</title>
            <description>Patients receive paclitaxel IV over 1 hour on days 1, 8, and 15 and carboplatin IV over 30 minutes on day 1. Patients also receive bevacizumab IV over 30-90 minutes on day 1 in courses 2-6. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone in courses 7-22 in the absence of disease progression or unacceptable toxicity.
Bevacizumab: Given IV
Carboplatin: Given IV
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Paclitaxel, Bevacizumab, Carboplatin IP)</title>
            <description>Patients receive paclitaxel as in Arm I and carboplatin IP on day 1. Patients also receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as in Arm I.
Bevacizumab: Given IV
Carboplatin: Given IP
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Paclitaxel IP, Bevacizumab, Cisplatin IP)</title>
            <description>Patients receive paclitaxel IV over 3 hours on day 1, cisplatin IP on day 2, and paclitaxel IP on day 8. Patients also receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as in Arm I.
Bevacizumab: Given IV
Cisplatin: Given IP
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Paclitaxel: Given IP
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Survival</title>
          <description>Estimate the median duration of overall survival in months.</description>
          <population>Intention-to-treat: All enrolled patients</population>
          <units>Months</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="521"/>
                <count group_id="O2" value="518"/>
                <count group_id="O3" value="521"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.4" lower_limit="67.1">Not defined because there are insufficient number of participant with event.</measurement>
                    <measurement group_id="O2" value="74.2" lower_limit="61.9" upper_limit="78.4"/>
                    <measurement group_id="O3" value="67.6" lower_limit="63.5" upper_limit="74.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Quality of Life (QOL)</title>
        <description>QOL was measured with the FACT-O TOI score. Means at baseline are raw means. Scores are reported at all time points in the outcome measure table. FACT-O TOI is Trial outcome index (TOI) of the Functional assessment of cancer therapy (FACT) for ovarian cancer (FACT-O). The FACT-O TOI is composed of three subscales; Physical Well Being (PWB) ( 7 items), and Ovarian Cancer subscale (OCS) (12 items). Each item in the FACT-O TOI are scored using a 5 point scale (0=not at all; 1=a little bit; 2=somewhat;3=quite a bit;4=very much). A subscale score is computed as long as more thatn 50% of subscale items have been answered. A total score of the FACT-O items provide valid responses and all three subscales have valid scores. A score of the FACT-) TOI is ranged 0-104 with a larger score indicating a more preferred state of health-related quality of life (HRQOL).</description>
        <time_frame>Time points: Baseline, prior to cycle 4, prior to cycle 7, prior to cycle 13, prior to cycle 21, up to 84 weeks post starting treatment</time_frame>
        <population>Patients evaluable for PRO (Patient Reported Outcomes)/QOL (completed baseline and at least one follow-up assessment)</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Paclitaxel, Carboplatin, Bevacizumab)</title>
            <description>Patients receive paclitaxel IV over 1 hour on days 1, 8, and 15 and carboplatin IV over 30 minutes on day 1. Patients also receive bevacizumab IV over 30-90 minutes on day 1 in courses 2-6. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone in courses 7-22 in the absence of disease progression or unacceptable toxicity.
Bevacizumab: Given IV
Carboplatin: Given IV
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Paclitaxel, Bevacizumab, Carboplatin IP)</title>
            <description>Patients receive paclitaxel as in Arm I and carboplatin IP on day 1. Patients also receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as in Arm I.
Bevacizumab: Given IV
Carboplatin: Given IP
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Paclitaxel IP, Bevacizumab, Cisplatin IP)</title>
            <description>Patients receive paclitaxel IV over 3 hours on day 1, cisplatin IP on day 2, and paclitaxel IP on day 8. Patients also receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as in Arm I.
Bevacizumab: Given IV
Cisplatin: Given IP
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Paclitaxel: Given IP
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Quality of Life (QOL)</title>
          <description>QOL was measured with the FACT-O TOI score. Means at baseline are raw means. Scores are reported at all time points in the outcome measure table. FACT-O TOI is Trial outcome index (TOI) of the Functional assessment of cancer therapy (FACT) for ovarian cancer (FACT-O). The FACT-O TOI is composed of three subscales; Physical Well Being (PWB) ( 7 items), and Ovarian Cancer subscale (OCS) (12 items). Each item in the FACT-O TOI are scored using a 5 point scale (0=not at all; 1=a little bit; 2=somewhat;3=quite a bit;4=very much). A subscale score is computed as long as more thatn 50% of subscale items have been answered. A total score of the FACT-O items provide valid responses and all three subscales have valid scores. A score of the FACT-) TOI is ranged 0-104 with a larger score indicating a more preferred state of health-related quality of life (HRQOL).</description>
          <population>Patients evaluable for PRO (Patient Reported Outcomes)/QOL (completed baseline and at least one follow-up assessment)</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="492"/>
                <count group_id="O2" value="481"/>
                <count group_id="O3" value="464"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.5" spread="0.7"/>
                    <measurement group_id="O2" value="67.4" spread="0.7"/>
                    <measurement group_id="O3" value="67.7" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.8" spread="0.6"/>
                    <measurement group_id="O2" value="65.6" spread="0.6"/>
                    <measurement group_id="O3" value="61.9" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.1" spread="0.6"/>
                    <measurement group_id="O2" value="68.2" spread="0.6"/>
                    <measurement group_id="O3" value="65.7" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 13</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.3" spread="0.6"/>
                    <measurement group_id="O2" value="77.1" spread="0.6"/>
                    <measurement group_id="O3" value="78.4" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 21</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.7" spread="0.6"/>
                    <measurement group_id="O2" value="76.9" spread="0.7"/>
                    <measurement group_id="O3" value="78.2" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>84 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.3" spread="0.7"/>
                    <measurement group_id="O2" value="77.7" spread="0.7"/>
                    <measurement group_id="O3" value="79.4" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Neurotoxicity (Ntx)</title>
        <description>The FACT/GOG-NTX subscale (short version) contains 4 items measuring sensory neuropathy. Each item is scored using a 5 point Likert scale (0=not at all; 1=a little bit;2=somewhat;3=quite a bit; 4=very much). For each item, reversal was performed prior to score calculation so that a large score suggests less symptoms. According to the FACIT measurement system, the subscale score was calculated as the summation of the individual item scores if more than 50% of a subscale items were answered. When unanswered items existed, a subscale score was prorated by multiplying the mean of the answered item scores by the number of items in the subscale. The Ntx subscale score ranges from 0-16 with a large subscale score suggesting less symptom or better QOL.</description>
        <time_frame>Time points: Baseline, prior to cycle 4, prior to cycle 7, prior to cycle 13, prior to cycle 21, 84 weeks post starting treatment</time_frame>
        <population>Patients evaluable for PRO(Patient Reported Outcome)/QOL (completed baseline and at least one follow-up assessment).</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Paclitaxel, Carboplatin, Bevacizumab)</title>
            <description>Patients receive paclitaxel IV over 1 hour on days 1, 8, and 15 and carboplatin IV over 30 minutes on day 1. Patients also receive bevacizumab IV over 30-90 minutes on day 1 in courses 2-6. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone in courses 7-22 in the absence of disease progression or unacceptable toxicity.
Bevacizumab: Given IV
Carboplatin: Given IV
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Paclitaxel, Bevacizumab, Carboplatin IP)</title>
            <description>Patients receive paclitaxel as in Arm I and carboplatin IP on day 1. Patients also receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as in Arm I.
Bevacizumab: Given IV
Carboplatin: Given IP
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Paclitaxel IP, Bevacizumab, Cisplatin IP)</title>
            <description>Patients receive paclitaxel IV over 3 hours on day 1, cisplatin IP on day 2, and paclitaxel IP on day 8. Patients also receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as in Arm I.
Bevacizumab: Given IV
Cisplatin: Given IP
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Paclitaxel: Given IP
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Neurotoxicity (Ntx)</title>
          <description>The FACT/GOG-NTX subscale (short version) contains 4 items measuring sensory neuropathy. Each item is scored using a 5 point Likert scale (0=not at all; 1=a little bit;2=somewhat;3=quite a bit; 4=very much). For each item, reversal was performed prior to score calculation so that a large score suggests less symptoms. According to the FACIT measurement system, the subscale score was calculated as the summation of the individual item scores if more than 50% of a subscale items were answered. When unanswered items existed, a subscale score was prorated by multiplying the mean of the answered item scores by the number of items in the subscale. The Ntx subscale score ranges from 0-16 with a large subscale score suggesting less symptom or better QOL.</description>
          <population>Patients evaluable for PRO(Patient Reported Outcome)/QOL (completed baseline and at least one follow-up assessment).</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="492"/>
                <count group_id="O2" value="481"/>
                <count group_id="O3" value="464"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.4" spread="0.1"/>
                    <measurement group_id="O2" value="15.4" spread="0.1"/>
                    <measurement group_id="O3" value="15.4" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.9" spread="0.2"/>
                    <measurement group_id="O2" value="13.0" spread="0.2"/>
                    <measurement group_id="O3" value="13.6" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" spread="0.2"/>
                    <measurement group_id="O2" value="10.3" spread="0.2"/>
                    <measurement group_id="O3" value="10.9" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 13</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.1" spread="0.2"/>
                    <measurement group_id="O2" value="10.5" spread="0.2"/>
                    <measurement group_id="O3" value="9.2" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 21</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.4" spread="0.2"/>
                    <measurement group_id="O2" value="11.1" spread="0.2"/>
                    <measurement group_id="O3" value="11.0" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>84 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.9" spread="0.2"/>
                    <measurement group_id="O2" value="11.4" spread="0.2"/>
                    <measurement group_id="O3" value="11.5" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Fatigue</title>
        <description>Patient reported fatigue as measured with the Functional Assessment of Chronic Illness Therapy- Fatigue scale (FACIT-Fatigue). The FACIT-Fatigue contains 13 items. Each item was scored using a 5-point scale (0=not at all; 1=a little bit; 2=somewhat; 3=quite a bit; 4=very much). For the negative items, reversal was performed prior to score calculation. According to the FACIT measurement system, the Fatigue score was the summation of the individual item scores if more than 50% of subscale items were answered. When unanswered items existed, a subscale score was prorated by multiplying the mean of the answered item scores by the number of items in the scale. The FACIT-Fatigue score ranges 0-52 with a large score suggesting less fatigue.</description>
        <time_frame>Time points: Baseline, prior to cycle 4, prior to cycle 7, prior to cycle 13, prior to cycle 21, 84 weeks post starting treatment</time_frame>
        <population>Patients evaluable for PRO (Patient Reported Outcomes)/QOL. Evaluable patients have completed baseline and at least one follow-up assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Paclitaxel, Carboplatin, Bevacizumab)</title>
            <description>Patients receive paclitaxel IV over 1 hour on days 1, 8, and 15 and carboplatin IV over 30 minutes on day 1. Patients also receive bevacizumab IV over 30-90 minutes on day 1 in courses 2-6. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone in courses 7-22 in the absence of disease progression or unacceptable toxicity.
Bevacizumab: Given IV
Carboplatin: Given IV
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Paclitaxel, Bevacizumab, Carboplatin IP)</title>
            <description>Patients receive paclitaxel as in Arm I and carboplatin IP on day 1. Patients also receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as in Arm I.
Bevacizumab: Given IV
Carboplatin: Given IP
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Paclitaxel IP, Bevacizumab, Cisplatin IP)</title>
            <description>Patients receive paclitaxel IV over 3 hours on day 1, cisplatin IP on day 2, and paclitaxel IP on day 8. Patients also receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as in Arm I.
Bevacizumab: Given IV
Cisplatin: Given IP
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Paclitaxel: Given IP
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Fatigue</title>
          <description>Patient reported fatigue as measured with the Functional Assessment of Chronic Illness Therapy- Fatigue scale (FACIT-Fatigue). The FACIT-Fatigue contains 13 items. Each item was scored using a 5-point scale (0=not at all; 1=a little bit; 2=somewhat; 3=quite a bit; 4=very much). For the negative items, reversal was performed prior to score calculation. According to the FACIT measurement system, the Fatigue score was the summation of the individual item scores if more than 50% of subscale items were answered. When unanswered items existed, a subscale score was prorated by multiplying the mean of the answered item scores by the number of items in the scale. The FACIT-Fatigue score ranges 0-52 with a large score suggesting less fatigue.</description>
          <population>Patients evaluable for PRO (Patient Reported Outcomes)/QOL. Evaluable patients have completed baseline and at least one follow-up assessment.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="492"/>
                <count group_id="O2" value="481"/>
                <count group_id="O3" value="464"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.3" spread="0.3"/>
                    <measurement group_id="O2" value="35.1" spread="0.3"/>
                    <measurement group_id="O3" value="35.3" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.5" spread="0.3"/>
                    <measurement group_id="O2" value="32.0" spread="0.3"/>
                    <measurement group_id="O3" value="31.3" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.7" spread="0.3"/>
                    <measurement group_id="O2" value="32.7" spread="0.3"/>
                    <measurement group_id="O3" value="32.4" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 13</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.7" spread="0.3"/>
                    <measurement group_id="O2" value="35.5" spread="0.3"/>
                    <measurement group_id="O3" value="35.9" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 21</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.5" spread="0.3"/>
                    <measurement group_id="O2" value="35.1" spread="0.3"/>
                    <measurement group_id="O3" value="36.3" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>84 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.7" spread="0.3"/>
                    <measurement group_id="O2" value="36.0" spread="0.3"/>
                    <measurement group_id="O3" value="36.5" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Nausea</title>
        <description>Nausea was measured with the a single item ,â I have nauseaâ from the FACT-O TOI</description>
        <time_frame>Time points: Baseline, prior to cycle 4, prior to cycle 7, prior to cycle 13, prior to cycle 21, 84 weeks post starting treatment</time_frame>
        <population>Patients evaluable for PRO (Patient Reported Outcomes)/QOL are patients who completed baseline and at least one follow-up assessment</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Paclitaxel, Carboplatin, Bevacizumab)</title>
            <description>Patients receive paclitaxel IV over 1 hour on days 1, 8, and 15 and carboplatin IV over 30 minutes on day 1. Patients also receive bevacizumab IV over 30-90 minutes on day 1 in courses 2-6. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone in courses 7-22 in the absence of disease progression or unacceptable toxicity.
Bevacizumab: Given IV
Carboplatin: Given IV
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Paclitaxel, Bevacizumab, Carboplatin IP)</title>
            <description>Patients receive paclitaxel as in Arm I and carboplatin IP on day 1. Patients also receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as in Arm I.
Bevacizumab: Given IV
Carboplatin: Given IP
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
          <group group_id="O3">
            <title>Arm III (Paclitaxel IP, Bevacizumab, Cisplatin IP)</title>
            <description>Patients receive paclitaxel IV over 3 hours on day 1, cisplatin IP on day 2, and paclitaxel IP on day 8. Patients also receive bevacizumab as in Arm I. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity. Patients then receive bevacizumab alone as in Arm I.
Bevacizumab: Given IV
Cisplatin: Given IP
Laboratory Biomarker Analysis: Correlative studies
Paclitaxel: Given IV
Paclitaxel: Given IP
Quality-of-Life Assessment: Ancillary studies</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Nausea</title>
          <description>Nausea was measured with the a single item ,â I have nauseaâ from the FACT-O TOI</description>
          <population>Patients evaluable for PRO (Patient Reported Outcomes)/QOL are patients who completed baseline and at least one follow-up assessment</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="492"/>
                <count group_id="O2" value="481"/>
                <count group_id="O3" value="464"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.04"/>
                    <measurement group_id="O2" value="0.4" spread="0.04"/>
                    <measurement group_id="O3" value="0.4" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.04"/>
                    <measurement group_id="O2" value="0.7" spread="0.04"/>
                    <measurement group_id="O3" value="1.1" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.04"/>
                    <measurement group_id="O2" value="0.5" spread="0.04"/>
                    <measurement group_id="O3" value="0.7" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 13</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.03"/>
                    <measurement group_id="O2" value="0.3" spread="0.03"/>
                    <measurement group_id="O3" value="0.2" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prior to cycle 21</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.04"/>
                    <measurement group_id="O2" value="0.4" spread="0.04"/>
                    <measurement group_id="O3" value="0.3" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>84 Weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.04"/>
                    <measurement group_id="O2" value="0.4" spread="0.04"/>
                    <measurement group_id="O3" value="0.3" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>AEs were recorded from the initiation of any study treatment up until 30 days following the last cycle of study treatment.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Arm I (Paclitaxel, Carboplatin, Bevcizumab IV)</title>
          <description>Six cycles of Paclitaxel 80mg/m2 IV over ` hours days 1, 8 and 15. Carboplatin AUC 6 IV on day 1, Bevacizumab 15mg/kg IV on day 1 beginning on cycle 2, followed by bevacizumab 15mg/kg for cycles 7-22.</description>
        </group>
        <group group_id="E2">
          <title>Arm II (Paclitaxel,carboplatinIP, Bevacizumab IP)</title>
          <description>Six cycles of Paclitaxel 80mg/m2 IV over 1 hour days 1, 8, and 15, Carboplatin AUC 6 IP on day1, Bevacizumab 15mg/kg IV on day 1 beginning on cycle 2 followed by bevacizumab 15mg/KG for cycles 7-22</description>
        </group>
        <group group_id="E3">
          <title>Arm III (Paclitaxel IP, Cisplatin, Bevacizumab)</title>
          <description>Six cycles of Paclitaxel 135 mg/m2 IV over 3 hours day 1, Cisplatin 75 mg/m2 IP on day 2, Paclitaxel 60 mg/m2 IP on day 8, Bevacizumab 15 mg/kg IV on day 1 beginning with cycle 2, followed by bevacizumab 15 mg/kg for cycles 7-22.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>CTCAE (3.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="156" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="179" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="215" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Neutrophils</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Platelets</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Blood/Bone Marrow - Other</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Leukocytes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemoglobin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Lymphocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Sinus/Node (S/N) Arrhythmia: Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>S/N Arrhythmia: Sinus Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cardiac Ischemia/Infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Right Ventricular Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Restrictive Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Left Venticular Diastolic Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Left Ventricular Systolic Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cardiac General - Other</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blurred Vision</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Fistula, Gi - Colon/Cecum/Appendix</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Perforation, Gastrointestinal (GI) - Duodenum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Perforation, Gi - Appendix</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gi - Ileum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Necrosis, Gi - Small Bowel Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Perforation, Gi - Colon</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gi - Small Bowel Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gi - Rectum</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gi - Colon</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Esophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Leak, Gi - Large Bowel</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Leak, Gi - Leak Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gi - Anus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Distention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gi - Abdomen Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gi - Gallbladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mucositis (Functional/Sympt) - Oral Cavity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gi - Duodenal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gi - Small Bowel Nos</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gi - Jejunum</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Perforation, Gi - Small Bowel Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Gastrointestinal - Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Perforation, Gi - Ileum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Weight Loss</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Rigors/Chills</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Death No Ctcae Term - Disease Progression Not otherwise specified (NOS)</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Death No Ctcae Term - Death Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Death No Ctcae Term - Multi-Organ Failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Death No Ctcae Term - Sudden Death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain - Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Chest /Thorax Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Head/Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Neck</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Joint</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Oral Cavity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Esophagus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Abdominal Pain Nos</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Cardiac/ Heart</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Syndromes - Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatobiliary/Pancreas - Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic Reaction/Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection (Inf) with Grade 3 Or 4 Absolute Neutrophil Count (Anc): Wound</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Blood</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Anal/Perianal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Skin (Cellulitis)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Upper Airway Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Mediastinum Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Lung(Pneumonia)</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Gallbladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Blood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Wound</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Appendix</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Skin(Cellulitis)</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Catheter-Related</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Febrile Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Lung (Pneumonia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Dental-Tooth</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Urinary Tract Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Abdomen Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Blood</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Infection - Other</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Opportunisitic Inf Assoc. W/Gr 2 Lymphopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Colitis, Infectious (Eg.C. Difficile)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Bronchus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Abdomen Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Up. Aerodigestive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Pelvis Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc:peritoneal Cavity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Catheter-Related</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Rectum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Foreign Body</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Abdomen Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Skin (Cellulitis)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Upper Airway Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Anal/Perianal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Lung (Pneumonia)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Kidney</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Urinary Tract Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Catheter-Related</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Metabolic/Laboratory - Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Creatinine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Alanine Aminotransferase (Alt)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hyponatremia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hyperkalemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hyperglycemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypokalemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypercalcemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypomagnesemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Musculoskeletal/St: Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Device/Prosthesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Muscle Weakness - Whole Body/Generalized</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Muscle Weakness - Extremity-Upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>2nd Malignancy: Poss. Related To Cancer Rx</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Neurology - Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mood Alteration - Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Speech Impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Personality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cognitive Disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Central Nervous System (Cns) Ischemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Confusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Memory Impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Neuropathy-Sensory</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal/Genitourinary - Other</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Perforation, Gu - Vagina</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Leak, Gu - Vagina</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Urinary Color Change</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gu - Ureter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gu - Vagina</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gu - Bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary: Other</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Nasal/Paranasal Reactions</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Injection Site Reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Wound Complication, Non-Infectious</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>International Normalized ratio (Inr)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Genitourinary (Gu) - Urinary Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gu - Vagina</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Rectum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Peritoneal Cavity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Upper Gi Nos</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage With Surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage/Pulmonary - Nose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Lower Gi Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Stomach</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Colon</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Cns</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Thrombosis/Embolism (Vascular Access-Related)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Thrombosis/Thrombus/Embolism</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>CTCAE (3.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="511" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="510" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="507" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Neutrophils</sub_title>
                <counts group_id="E1" subjects_affected="484" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="473" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="462" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Platelets</sub_title>
                <counts group_id="E1" subjects_affected="371" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="370" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="253" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Blood/Bone Marrow - Other</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Leukocytes</sub_title>
                <counts group_id="E1" subjects_affected="486" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="480" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="459" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Lymphopenia</sub_title>
                <counts group_id="E1" subjects_affected="48" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="55" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="44" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemolysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemoglobin</sub_title>
                <counts group_id="E1" subjects_affected="499" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="490" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="483" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Lymphedema-Related Fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Lymphatics - Other</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Lymphocele</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Edema: Trunk/Genital</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Edema: Limb</sub_title>
                <counts group_id="E1" subjects_affected="101" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="106" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="94" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Edema: Head And Neck</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dermal Change</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Prolonged Q wave and tc wave Interval</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>S/N Arrhythmia: Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Conduction Abnml: Conduction Abnormality Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cardiac Arrhythmia - Other</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Conduction Abnml: Av Block 1st Degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmia - Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>S/N Arrhythmia: Sinus Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Vasovagal Episode</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>S/N Arrhythmia: Sinus Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmia - Pvcs</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmia - Trigeminny</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmia - Bigeminy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>S/N Arrhythmia: Atrial Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cardiac Ischemia/Infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Right Ventricular Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pulmonary Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="205" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="189" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="242" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Valvular Heart Disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Left Venticular Diastolic Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Lt Ventricular Systolic Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cardiac General - Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cardiac Troponin I (Ctni)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cardiac Troponin T (Ctnt)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="29" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Otitis Middle Ear</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Auditory/Ear - Other</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Otitis External Ear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hearing (Without Monitoring Program)</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="60" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="59" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hearing (Monitoring Program)</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hot Flashes</sub_title>
                <counts group_id="E1" subjects_affected="103" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="84" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="89" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Diabetes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypoparathyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Adrenal Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Endocrine - Other</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cushingoid</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ocular/Visual - Other</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Vitreous Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Nystagmus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Nyctalopia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Watery Eye</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dry Eye</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ocular Surface Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Flashing Lights/Floaters</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Blurred Vision</sub_title>
                <counts group_id="E1" subjects_affected="89" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="82" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="78" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Keratitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Eyelid Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Fistula, Gi - Colon/Cecum/Appendix</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Perforation, Gi - Duodenum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ulcer,gi - Colon</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gi - Ileum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Proctitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ulcer,gi - Anus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Salivary Gland Changes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Perforation, Gi - Colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ulcer,gi - Duodenum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gi - Ileum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dental: Periodontal</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gi - Small Bowel Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gi - Rectum</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gi - Colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ulcer,gi - Stoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Esophagitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="45" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="24" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Heartburn</sub_title>
                <counts group_id="E1" subjects_affected="97" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="80" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="107" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ulcer,gi - Stomach</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dental: Teeth</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mucositis (Functional/Sympt) - Pharynx</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gi - Jejunum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gi - Anus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Leak, Gi - Rectum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dental: Teeth Development</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Distention</sub_title>
                <counts group_id="E1" subjects_affected="47" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="63" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="93" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Taste Alteration</sub_title>
                <counts group_id="E1" subjects_affected="117" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="100" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="97" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Incontinence, Anal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gi - Abdomen Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dry Mouth</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mucositis (Functional/Sympt) - Stomach</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gi - Gallbladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mucositis (Functional/Sympt) - Rectum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mucositis (Functional/Sympt) - Oral Cavity</sub_title>
                <counts group_id="E1" subjects_affected="89" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="80" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="48" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Stricture, Gi - Colon</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gi - Small Bowel Nos</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gi - Oral Cavity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mucositis (Clinical Exam) - Stomach</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mucositis (Functional/Sympt) - Anus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Perforation, Gi - Small Bowel Nos</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mucositis (Clinical Exam) - Oral Cavity</sub_title>
                <counts group_id="E1" subjects_affected="117" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="107" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="76" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mucositis (Clinical Exam) - Larynx</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mucositis (Clinical Exam) - Esophagus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="158" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="160" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="215" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="161" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="159" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="211" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="52" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="93" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="321" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="323" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="335" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Stricture, Gi - Small Bowel Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="317" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="331" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="393" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Malabsorption</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Gastrointestinal - Other</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Perforation, Gi - Ileum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Leak, Gi - Stomach</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="224" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="263" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="264" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Prolapse Of Stoma, Gi</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mucositis (Clinical Exam) - Pharynx</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Perforation, Gi - Jejunum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Constitutional Symptoms - Other</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Sweating</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Weight Gain</sub_title>
                <counts group_id="E1" subjects_affected="121" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="105" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="82" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Patient Odor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" subjects_affected="55" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="62" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Weight Loss</sub_title>
                <counts group_id="E1" subjects_affected="64" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="80" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="97" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Rigors/Chills</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="37" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="465" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="457" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="451" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="160" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="151" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="150" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Death No Ctcae Term - Death Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain - Other</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Urethra</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Perineum</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Pelvis</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="37" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Breast</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Vagina</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Chest /Thorax Nos</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="36" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="33" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Chest Wall</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Throat/Pharynx/Larynx</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="36" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Pleura</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Larynx</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Eye</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Head/Headache</sub_title>
                <counts group_id="E1" subjects_affected="234" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="201" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="209" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Neck</sub_title>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Intestine</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Extremity-Limb</sub_title>
                <counts group_id="E1" subjects_affected="143" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="133" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="122" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Buttock</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Back</sub_title>
                <counts group_id="E1" subjects_affected="120" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="115" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="102" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Joint</sub_title>
                <counts group_id="E1" subjects_affected="235" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="210" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="199" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Bone</sub_title>
                <counts group_id="E1" subjects_affected="48" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="44" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="41" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Lymph Node</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Gallbladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Kidney</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Bladder</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Pain Nos</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Stomach</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Rectum</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Peritoneum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Oral Cavity</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Esophagus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Dental/Teeth/Peridontal</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Abdominal Pain Nos</sub_title>
                <counts group_id="E1" subjects_affected="243" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="311" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="346" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Scalp</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Oral - Gums</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Skin</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Lip</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Middle Ear</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: External Ear</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Cardiac/ Heart</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Face</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Muscle</sub_title>
                <counts group_id="E1" subjects_affected="141" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="127" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="127" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Anus</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pain: Sinus</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Syndromes - Other</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cytokine Release Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Flu-Like Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Liver Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy/Immunology - Other</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Allergic Reaction/Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="54" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="141" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="119" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="103" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Autoimmune Reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Wound</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Blood</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Foreign Body</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Dental-Tooth</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Anal/Perianal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Ungual (Nails)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Skin (Cellulitis)</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Middle Ear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: External Ear</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Vulva</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Upper Airway Nos</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Paranasal</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Nose</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Neck Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Infection (Inf) With Normal Or Grade 1 Or 2 Absolute Neutrophil Count (Anc): Mediastinum Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Lung(Pneumonia)</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Larynx</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Eye Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Peritoneal Cavity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Small Bowel Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Esophagus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Soft Tissue Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Joint</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Biliary Tree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Urethra</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Blood</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Wound</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Small Bowel Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Oral Cavity-Gums</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Otitis Media Nos</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Skin(Cellulitis)</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Catheter-Related</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Febrile Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Lip/Perioral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Rectum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Infection (Inf) Unknown Absolute Neutrophil Count (Anc): Lung (Pneumonia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Nose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Sinus</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Dental-Tooth</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Colon</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Viral Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Urinary Tract Nos</sub_title>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="42" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="46" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Abdomen Nos</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Ungual (Nails)</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Blood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Stomach</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Stomach</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Infection - Other</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Bladder (Urinary)</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Opportunisitic Inf Assoc. W/Gr 2 Lymphopenia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Colitis, Infectious (Eg.C. Difficile)</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Nerve-Peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Oral Cavity-Gums</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Vulva</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Vagina</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Bronchus</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Abdomen Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Mucosa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Pelvis Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Upper Airway Nos</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Upper Aerodigestive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Pharynx</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Vagina</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Sinus</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Pelvis Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Pharynx</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Mucosa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Bronchus</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Eye Nos</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Nerve-Cranial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Soft Tissue Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc:peritoneal Cavity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Urinary Tract Nos</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Urethra</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Bladder (Urinary)</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Foreign Body</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Catheter-Related</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Rectum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Peritoneal Cavity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Oral Cavity-Gums</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Foreign Body</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Dental-Tooth</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Appendix</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Anal/Perianal</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Abdomen Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Skin (Cellulitis)</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Lip/Perioral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Middle Ear</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: External Ear</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Vagina</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Upper Airway Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Upper Aerodigestive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Anal/Perianal</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Sinus</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Nose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Mucosa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Lung (Pneumonia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Eye Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Conjunctiva</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Kidney</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Ungual (Nails)</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Soft Tissue Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Lymphatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: Bladder</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf Unknown Anc: Esophagus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Urinary Tract Nos</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Nml Or Gr 1 Or 2 Anc: External Ear</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Urethra</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Catheter-Related</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Inf W/Gr 3 Or 4 Anc: Kidney</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Ast</sub_title>
                <counts group_id="E1" subjects_affected="104" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="95" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="85" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Gfr</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Metabolic/Laboratory - Other</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="33" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Alkalosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cholesterol,serum High</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="62" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="65" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="60" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemoglobinuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Creatinine</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="132" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypoalbuminemia</sub_title>
                <counts group_id="E1" subjects_affected="66" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="74" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="96" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Gamma-Glutamyl Transferase (Ggt)</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Alanine Aminotransferases (Alt)</sub_title>
                <counts group_id="E1" subjects_affected="98" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="109" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="77" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Alkaline Phosphatase</sub_title>
                <counts group_id="E1" subjects_affected="61" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="86" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="73" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Bilirubin</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Lipase</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypermagnesemia</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypophosphatemia</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="38" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hyponatremia</sub_title>
                <counts group_id="E1" subjects_affected="97" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="113" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="141" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hyperuricemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridemia</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Creatine Phosphokinase (Cpk)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Bicarbonate, Serum-Low</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Amylase</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypernatremia</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypocalcemia</sub_title>
                <counts group_id="E1" subjects_affected="64" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="72" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="96" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hyperkalemia</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="49" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hyperglycemia</sub_title>
                <counts group_id="E1" subjects_affected="148" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="143" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="152" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypokalemia</sub_title>
                <counts group_id="E1" subjects_affected="74" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="91" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="125" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypercalcemia</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="37" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="45" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypomagnesemia</sub_title>
                <counts group_id="E1" subjects_affected="130" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="190" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="242" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Myositis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fibrosis-Deep Connective Tissue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Trismus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Musculoskeletal/St: Other</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Device/Prosthesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Joint-Function</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Joint Effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fibrosis-Cosmesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Extremity-Upper (Function)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Gait/Walking</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cervical Spine Rom</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Muscle Weakness - Whole Body/Generalized</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="52" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="71" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Muscle Weakness - Trunk</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Muscle Weakness - Right-Sided</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Muscle Weakness - Left-Sided</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Muscle Weakness - Extremity-Upper</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Muscle Weakness - Extremity-Lower</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>2nd Mal: Poss. Related To Cancer Rx</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="24" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Involuntary Movement</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Psychosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Myelitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Neurology - Other</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mental Status</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Laryngeal Nerve Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cns Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mood Alteration - Euphoria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mood Alteration - Depression</sub_title>
                <counts group_id="E1" subjects_affected="115" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="91" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="98" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mood Alteration - Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="111" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="102" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="122" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Mood Alteration - Agitation</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Speech Impairment</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Personality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Leukoencephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cognitive Disturbance</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cns Ischemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Confusion</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Memory Impairment</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="35" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="35" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="113" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="107" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="111" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Neuropathy,cranial - Cn Viii Hearing/Balance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Neuropathy,cranial - Cn Vii Motor-Face</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Neuropathy,cranial - Cn V Motor-Jaw Muscles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Neuropathy,cranial - Cn Ii Vision</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Neuropathy,cranial - Cn I Smell</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Neuropathy-Sensory</sub_title>
                <counts group_id="E1" subjects_affected="406" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="394" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="407" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Neuropathy-Motor</sub_title>
                <counts group_id="E1" subjects_affected="48" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="56" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="35" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal/Genitourinary - Other</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Stricture, Anastomotic, Gu - Ureter</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Prolapse Of Stoma, Gu</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Perforation, Gu - Vagina</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Leak, Gu - Vagina</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Leak, Gu - Bladder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Urinary Color Change</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Urinary Electrolyte Wasting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gu - Ureter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Obstruction, Gu - Bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Incontinence, Urinary</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gu - Vagina</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gu - Genital Tract-Female</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Fistula, Gu - Bladder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Bladder Spasm</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Urinary Frequency</sub_title>
                <counts group_id="E1" subjects_affected="57" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="63" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="63" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Libido</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Irregular Menses</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Vaginal Dryness</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Sexual/Reproductive Function: Other</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Vaginitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Vaginal Mucositis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Vaginal Discharge</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary: Other</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Airway Obstruction - Trachea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Airway Obstruction - Bronchus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Nasal/Paranasal Reactions</sub_title>
                <counts group_id="E1" subjects_affected="101" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="81" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="67" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Edema, Larynx</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Voice Changes</sub_title>
                <counts group_id="E1" subjects_affected="75" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="57" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="58" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hiccoughs</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="143" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="147" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="116" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ards</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" subjects_affected="202" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="203" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="143" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Nail Changes</sub_title>
                <counts group_id="E1" subjects_affected="137" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="113" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="48" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Photosensitivity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Injection Site Reaction</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hair Loss/Alopecia (Scalp Or Body)</sub_title>
                <counts group_id="E1" subjects_affected="402" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="378" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="377" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Erythema Multiforme</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dermatitis - Chemoradiation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hypopigmentation</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Induration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Cheilitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Wound Complication, Non-Infectious</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="43" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="46" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Bruising</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="49" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="186" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="192" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="121" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dry Skin</sub_title>
                <counts group_id="E1" subjects_affected="61" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="29" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Decubitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Atrophy, Skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Telangiectasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="39" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="36" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Burn</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hand-Foot</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Dermatology/Skin - Other</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hyperpigmentation</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Ulceration</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Intra-Operative (Op) Injury: Nerves: Peripheral Motor Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Intra-Op Injury: Teeth</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Intra-Op Injury: Nasal Cavity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Intra-Op Injury: Kidney</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Intra-Op Injury: Small Bowel Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Intra-Op Injury: Peritoneal Cavity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Intra-Op Injury: Colon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Intra-Op Injury: Abdomen Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Intra-Op Injury: Adrenal Gland</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Inr</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Partial Throboplastin Time (Ptt)</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gu - Stoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gu - Urinary Nos</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gu - Vagina</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage/Pulmonary - Bronchopulmonary Nos</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage/Pulmonary - Lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage/Pulmonary - Pharynx</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Rectum</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage/Pulmonary - Respiratory Tract Nos</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Stoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Varices (Rectal)</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Peritoneal Cavity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Upper Gi Nos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage/Pulmonary - Nose</sub_title>
                <counts group_id="E1" subjects_affected="261" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="231" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="184" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Anus</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Esophagus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gu - Ureter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Duodenum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Lower Gi Nos</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Oral Cavity</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gu - Kidney</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gu - Bladder</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Stomach</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Gi - Colon</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage, Cns</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Petechiae</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Hemorrhage/Bleeding - Other</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Vascular - Other</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Visceral Arterial Ischemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Vein Injury - Other Nos</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Peripheral Arterial Ischemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Vein Injury - Extremity-Lower</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Thrombosis/Embolism (Vascular Access-Related)</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Thrombosis/Thrombus/Embolism</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="30" subjects_at_risk="508"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="511"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="510"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="508"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Linda Gedeon for Mark Brady, PhD</name_or_title>
      <organization>NRG Oncology</organization>
      <phone>716-845-1169</phone>
      <email>lgedeon@gogstats.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

